Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	4-hydroxybutyrate receptor activity	SLC52A2 SLC52A1	1.68e-04	2	259	2	GO:0062124
GeneOntologyMolecularFunction	beta-catenin binding	APC2 CDHR5 KDM6B AXIN1 MED12L SHROOM2 ASH2L CDH3	1.73e-04	120	259	8	GO:0008013
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	ABR ARHGEF11 PLEKHG5 VAV2 ARHGEF12 RAPGEF1 PLEKHG4B PLEKHG3 RASGEF1C KNDC1 PSD4	2.26e-04	231	259	11	GO:0005085
GeneOntologyMolecularFunction	nucleoside-triphosphatase regulator activity	ABR ARHGEF11 PLEKHG5 ARHGAP22 TBC1D4 SGSM2 TBC1D14 VAV2 ARHGEF12 RAPGEF1 SYDE1 PLEKHG4B LLGL2 PLEKHG3 RASGEF1C KNDC1 PSD4	3.57e-04	507	259	17	GO:0060589
GeneOntologyMolecularFunction	GTPase regulator activity	ABR ARHGEF11 PLEKHG5 ARHGAP22 TBC1D4 SGSM2 TBC1D14 VAV2 ARHGEF12 RAPGEF1 SYDE1 PLEKHG4B LLGL2 PLEKHG3 RASGEF1C KNDC1 PSD4	3.57e-04	507	259	17	GO:0030695
GeneOntologyMolecularFunction	cytoskeletal protein binding	PDE4B KIF26A AXL APC2 SYNPO2L KIF12 DBN1 CCDC88B KIF24 WASH6P PTPN4 MTCL1 FAM110C PDLIM2 NPHS1 MAPK8IP1 SHROOM3 GTSE1 NUMA1 RELA SHROOM2 EML3 FMNL3 SHROOM1 LLGL2 PLEKHG3 TTLL4 MYO15A	5.14e-04	1099	259	28	GO:0008092
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	PCDHA9 TRO CDHR5 ROBO3 SDK1 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 CDH3 PCDH8	1.45e-08	187	258	15	GO:0007156
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	PCDHA9 TRO CDHR5 ROBO3 SDK1 ADGRL3 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 CDH3 PCDH8	2.27e-06	313	258	16	GO:0098742
Domain	Cadherin_tail	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	2.97e-08	37	255	8	PF15974
Domain	Cadherin_CBD	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	2.97e-08	37	255	8	IPR031904
Domain	Cadherin_CS	PCDHA9 CDHR5 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 CDH3 PCDH8	3.14e-08	109	255	12	IPR020894
Domain	CADHERIN_1	PCDHA9 CDHR5 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 CDH3 PCDH8	4.73e-08	113	255	12	PS00232
Domain	CADHERIN_2	PCDHA9 CDHR5 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 CDH3 PCDH8	5.22e-08	114	255	12	PS50268
Domain	-	PCDHA9 CDHR5 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 CDH3 PCDH8	5.22e-08	114	255	12	2.60.40.60
Domain	CA	PCDHA9 CDHR5 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 CDH3 PCDH8	5.76e-08	115	255	12	SM00112
Domain	Cadherin-like	PCDHA9 CDHR5 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 CDH3 PCDH8	6.34e-08	116	255	12	IPR015919
Domain	Cadherin	PCDHA9 CDHR5 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 CDH3 PCDH8	7.68e-08	118	255	12	IPR002126
Domain	Cadherin_2	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 PCDH8	2.35e-07	65	255	9	PF08266
Domain	Cadherin_N	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 PCDH8	2.35e-07	65	255	9	IPR013164
Domain	Cadherin	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 CDH3 PCDH8	4.22e-07	113	255	11	PF00028
Domain	-	ABR ARHGEF11 PLEKHG5 SPRED3 ARHGAP22 PTPN4 PTPN14 TBC1D4 VAV2 MAPK8IP1 SH2B3 ARHGEF12 TNS2 NIBAN2 PLEKHG4B MTMR4 PLEKHO2 PLEKHG3 GAB1 PSD4	4.66e-07	391	255	20	2.30.29.30
Domain	PH_dom-like	ABR ARHGEF11 PLEKHG5 SPRED3 ARHGAP22 PTPN4 PTPN14 TBC1D4 VAV2 MAPK8IP1 SH2B3 ARHGEF12 TNS2 NIBAN2 PLEKHG4B MTMR4 PLEKHO2 PLEKHG3 GAB1 PSD4	1.76e-06	426	255	20	IPR011993
Domain	ASD1	SHROOM3 SHROOM2 SHROOM1	2.52e-06	3	255	3	PF08688
Domain	ASD1_dom	SHROOM3 SHROOM2 SHROOM1	2.52e-06	3	255	3	IPR014800
Domain	ASD1	SHROOM3 SHROOM2 SHROOM1	2.52e-06	3	255	3	PS51306
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	9.96e-06	4	255	3	IPR029423
Domain	Shroom_fam	SHROOM3 SHROOM2 SHROOM1	9.96e-06	4	255	3	IPR027685
Domain	ASD2_dom	SHROOM3 SHROOM2 SHROOM1	9.96e-06	4	255	3	IPR014799
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	9.96e-06	4	255	3	PF14914
Domain	ASD2	SHROOM3 SHROOM2 SHROOM1	9.96e-06	4	255	3	PF08687
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A	9.96e-06	4	255	3	IPR032754
Domain	ASD2	SHROOM3 SHROOM2 SHROOM1	9.96e-06	4	255	3	PS51307
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A	9.96e-06	4	255	3	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A	9.96e-06	4	255	3	IPR015753
Domain	DH_1	ABR ARHGEF11 PLEKHG5 VAV2 ARHGEF12 PLEKHG4B PLEKHG3	2.35e-05	63	255	7	PS00741
Domain	RhoGEF	ABR ARHGEF11 PLEKHG5 VAV2 ARHGEF12 PLEKHG4B PLEKHG3	3.88e-05	68	255	7	SM00325
Domain	RhoGEF	ABR ARHGEF11 PLEKHG5 VAV2 ARHGEF12 PLEKHG4B PLEKHG3	4.69e-05	70	255	7	PF00621
Domain	DH_2	ABR ARHGEF11 PLEKHG5 VAV2 ARHGEF12 PLEKHG4B PLEKHG3	4.69e-05	70	255	7	PS50010
Domain	-	ABR ARHGEF11 PLEKHG5 VAV2 ARHGEF12 PLEKHG4B PLEKHG3	5.15e-05	71	255	7	1.20.900.10
Domain	DH-domain	ABR ARHGEF11 PLEKHG5 VAV2 ARHGEF12 PLEKHG4B PLEKHG3	5.15e-05	71	255	7	IPR000219
Domain	PH	ABR ARHGEF11 PLEKHG5 ARHGAP22 VAV2 SH2B3 ARHGEF12 NIBAN2 PLEKHG4B PLEKHO2 PLEKHG3 GAB1 PSD4	1.23e-04	278	255	13	SM00233
Domain	PH_DOMAIN	ABR ARHGEF11 PLEKHG5 ARHGAP22 VAV2 SH2B3 ARHGEF12 NIBAN2 PLEKHG4B PLEKHO2 PLEKHG3 GAB1 PSD4	1.27e-04	279	255	13	PS50003
Domain	PH_domain	ABR ARHGEF11 PLEKHG5 ARHGAP22 VAV2 SH2B3 ARHGEF12 NIBAN2 PLEKHG4B PLEKHO2 PLEKHG3 GAB1 PSD4	1.32e-04	280	255	13	IPR001849
Domain	PUFD	BCORL1 BCOR	1.86e-04	2	255	2	IPR032365
Domain	PUFD	BCORL1 BCOR	1.86e-04	2	255	2	PF16553
Domain	BCOR	BCORL1 BCOR	1.86e-04	2	255	2	PF15808
Domain	BCOR	BCORL1 BCOR	1.86e-04	2	255	2	IPR031628
Domain	Riboflavin_transptr	SLC52A2 SLC52A1	5.52e-04	3	255	2	IPR009357
Domain	hSH3	PRAM1 FYB1	5.52e-04	3	255	2	PF14603
Domain	RGS-like_dom	ARHGEF11 ARHGEF12	5.52e-04	3	255	2	IPR015212
Domain	DUF1011	SLC52A2 SLC52A1	5.52e-04	3	255	2	PF06237
Domain	hSH3	PRAM1 FYB1	5.52e-04	3	255	2	IPR029294
Domain	RGS-like	ARHGEF11 ARHGEF12	5.52e-04	3	255	2	PF09128
Domain	PDZ	SYNPO2L ARHGEF11 PTPN4 PDLIM2 SHROOM3 ARHGEF12 SHROOM2 PRX	7.19e-04	141	255	8	PF00595
Domain	SH3_domain	NCF1 STAC PRAM1 MIA2 CASKIN1 VAV2 MAPK8IP1 MYO15A FYB1 TP53BP2	9.18e-04	220	255	10	IPR001452
Domain	PDZ	SYNPO2L ARHGEF11 PTPN4 PDLIM2 SHROOM3 ARHGEF12 SHROOM2 PRX	9.86e-04	148	255	8	SM00228
Domain	-	SYNPO2L ARHGEF11 PTPN4 PDLIM2 SHROOM3 ARHGEF12 SHROOM2 PRX	1.08e-03	150	255	8	2.30.42.10
Domain	PDZ	SYNPO2L ARHGEF11 PTPN4 PDLIM2 SHROOM3 ARHGEF12 SHROOM2 PRX	1.12e-03	151	255	8	PS50106
Domain	SH3_2	STAC MIA2 CASKIN1 VAV2 MYO15A FYB1	1.15e-03	86	255	6	PF07653
Domain	SH3_2	STAC MIA2 CASKIN1 VAV2 MYO15A FYB1	1.15e-03	86	255	6	IPR011511
Domain	PDZ	SYNPO2L ARHGEF11 PTPN4 PDLIM2 SHROOM3 ARHGEF12 SHROOM2 PRX	1.17e-03	152	255	8	IPR001478
Domain	zf-C2H2	ZNF142 ZBTB16 RREB1 CASZ1 GLI2 GLI4 ZNF541 ZNF687 ZNF574 ZNF316 ZBTB47 ZBTB7B ZNF496 YY1 HIVEP3 BCL6B ZFHX4 ZFHX2 ZBTB3 SP7	1.38e-03	693	255	20	PF00096
Domain	Znf_C2H2-like	ZNF142 ZBTB16 RREB1 CASZ1 GLI2 GLI4 ZNF541 ZNF687 ZNF574 ZNF316 ZBTB47 ZBTB7B ZNF496 YY1 HIVEP3 BCL6B ZFHX4 ZSCAN18 ZFHX2 ZFTA ZBTB3 SP7	1.40e-03	796	255	22	IPR015880
Domain	Znf_C2H2/integrase_DNA-bd	ZNF142 ZBTB16 RREB1 GLI2 GLI4 ZNF541 ZNF687 ZNF574 ZNF316 ZBTB47 ZBTB7B ZNF496 YY1 HIVEP3 BCL6B ZFHX4 ZSCAN18 ZFHX2 ZBTB3 SP7	1.41e-03	694	255	20	IPR013087
Domain	ZnF_C2H2	ZNF142 ZBTB16 RREB1 CASZ1 GLI2 GLI4 ZNF541 ZNF687 ZNF574 ZNF316 ZBTB47 ZBTB7B ZNF496 YY1 HIVEP3 BCL6B ZFHX4 ZSCAN18 ZFHX2 ZFTA ZBTB3 SP7	1.69e-03	808	255	22	SM00355
Domain	GDS_CDC24_CS	ABR ARHGEF11 VAV2 ARHGEF12	1.92e-03	39	255	4	IPR001331
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ABR ARHGEF11 SOWAHC PLEKHG5 ARHGAP22 VAV2 ARHGEF12 FMNL3 PLEKHG3	3.61e-05	142	161	9	MM15576
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ABR ARHGEF11 SOWAHC PLEKHG5 ARHGAP22 VAV2 ARHGEF12 FMNL3 PLEKHG3	5.27e-05	149	161	9	M41805
Pathway	REACTOME_DEATH_RECEPTOR_SIGNALING	TRADD ABR RTN4R OTUD1 ARHGEF11 PLEKHG5 VAV2 ARHGEF12 RELA	6.81e-05	154	161	9	M27697
Pathway	REACTOME_CDC42_GTPASE_CYCLE	ABR ARHGEF11 ARHGAP22 VAV2 ARHGEF12 SYDE1 FMNL3 PLEKHG4B PLEKHG3	7.17e-05	155	161	9	M41808
Pathway	REACTOME_CDC42_GTPASE_CYCLE	ABR ARHGEF11 ARHGAP22 VAV2 ARHGEF12 SYDE1 PLEKHG3	9.90e-05	94	161	7	MM15598
Pathway	REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	ABR RTN4R ARHGEF11 PLEKHG5 VAV2 ARHGEF12 RELA	1.21e-04	97	161	7	M9400
Pathway	REACTOME_DEATH_RECEPTOR_SIGNALING	TRADD ABR OTUD1 ARHGEF11 PLEKHG5 VAV2 ARHGEF12 RELA	2.24e-04	142	161	8	MM15431
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	TRNP1 SPHK2 ABCA2 SETD1B ABR KIF26A CDK12 RNF40 ANKLE1 ATG2A KDM6B SRCAP FHIP1B ARHGEF11 PLEKHG5 CASZ1 GGA3 FANCA PPP1R26 PRR12 LIME1 PNPLA6 TMEM259 SGSM2 CASKIN1 SLC52A2 CRAMP1 WNK2 ZNF687 SHROOM3 SH2B3 SZT2 GTSE1 ZNF316 AKNA MUS81 RAPGEF1 HUWE1 EML3 SBNO2 HIVEP3 LLGL2 AATK SCAP CELSR2 SUGP2 PLEKHO2 TTLL4 CTDP1 AGRN IL4R PPP1R16A RAB11FIP3	6.83e-27	1105	267	53	35748872
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	SPATA31E1 TRO APC2 ATG2A LDLRAD3 GGA3 PRR14 POM121 MIA2 GLI2 BSN WNK4 ADGRL3 WNK2 SHROOM3 GTSE1 NUMA1 MAGEE1 PRX PLEKHG4B AATK INAVA TMEM151A GAB1 TP53BP2	6.05e-15	430	267	25	35044719
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	6.67e-14	15	267	8	15640798
Pubmed	Systematic identification of SH3 domain-mediated human protein-protein interactions by peptide array target screening.	PCDHA9 ABR ARHGEF11 FANCA PTPN4 MIA2 FOXH1 WNK2 DLGAP4 PCDHA12 RAPGEF1 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 SHROOM2 PRX CELSR2 FYB1 TP53BP2	1.59e-13	329	267	21	17474147
Pubmed	Alpha protocadherins and Pyk2 kinase regulate cortical neuron migration and cytoskeletal dynamics via Rac1 GTPase and WAVE complex in mice.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	2.49e-13	17	267	8	29911975
Pubmed	CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	4.45e-13	18	267	8	15570159
Pubmed	Genomic organization of the family of CNR cadherin genes in mice and humans.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	4.45e-13	18	267	8	10662547
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ABCA2 KIF26A CDK12 RNF40 ATG2A KDM6B BCOR PLEKHG5 DMAP1 GGA3 LRRC47 MRC2 CASKIN1 MED12L BSN CRAMP1 WNK2 ZNF687 SHROOM3 FLYWCH1 SZT2 AKNA PCDHA3 FMNL3 TTLL4	6.29e-13	529	267	25	14621295
Pubmed	Developmental epigenetic modification regulates stochastic expression of clustered protocadherin genes, generating single neuron diversity.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	7.18e-12	24	267	8	24698270
Pubmed	Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	2.96e-11	28	267	8	15347688
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5	8.66e-11	11	267	6	9655502
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 PCDH8	2.12e-10	72	267	10	10380929
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHA9 CDHR5 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 PCDH8	2.80e-10	74	267	10	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 PCDH8	4.19e-10	77	267	10	10835267
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	PDE4B ABR APC2 DBN1 BCOR ARHGEF11 ITIH4 TMEM259 CASKIN1 MTCL1 BSN WNK2 VGF MAPK8IP1 SHROOM3 DLGAP4 NUMA1 ARHGEF12 HUWE1 ATF6B NOSIP MAP7D1 CELSR2 FAM171A2 ZSCAN18 DZIP3 AGRN PCDH8 TP53BP2	4.63e-10	963	267	29	28671696
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 CELSR2 PCDH8	6.17e-10	80	267	10	10716726
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 PCDH8	2.69e-09	68	267	9	11230163
Pubmed	Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	RNF40 PPP1R26 POM121 MRC2 CLUH OBSL1 MTMR4 AATK DZIP3 RAB11FIP3	6.88e-09	102	267	10	9734811
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	1.30e-08	57	267	8	32633719
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	1.49e-08	58	267	8	30377227
Pubmed	Proteins of the CNR family are multiple receptors for Reelin.	PCDHA9 PCDHA13 PCDHA8 PCDHA6 PCDHA5	1.95e-08	12	267	5	10612399
Pubmed	Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.	PCDHA9 RREB1 LRRC47 POM121 ADAMTS2 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	3.77e-08	193	267	12	22589738
Pubmed	A census of human transcription factors: function, expression and evolution.	RREB1 HOXA1 HOXD12 GLI2 NR1H2 TSC22D4 FOXH1 CRAMP1 ZNF541 EBF4 AKNA RELA YBX3 RFX7 ZBTB7B YY1 ATF6B TOE1 HIVEP3 BCL6B ZFHX4 ZFHX2 SIX5 ELK4 SP7	4.49e-08	908	267	25	19274049
Pubmed	The DNA sequence and comparative analysis of human chromosome 5.	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	1.18e-07	75	267	8	15372022
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1B TRO FHIP1B USP19 GGA3 SGSM2 CHD6 MTCL1 TET3 ADGRL3 DLGAP4 OBSL1 ARHGEF12 MAP7D1 SUGP2 DZIP3	1.29e-07	407	267	16	12693553
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZBTB16 ABR CASZ1 PTPN4 TBC1D4 PNPLA6 GLI2 SGSM2 TBC1D14 ARID5B CHD6 TSC22D4 TET3 CRAMP1 VAV2 WNK2 SHROOM3 SOBP SAMD4B CHD9 HUWE1 SHROOM2 SBNO2 PLEKHG4B HIVEP3 SUGP2 EFHD1 PLEKHG3 RASGEF1C KNDC1 ZFHX2 ELK4	1.71e-07	1489	267	32	28611215
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	KIF26A CASZ1 AXIN1 BSN TET3 CRAMP1 WNK2 AKNA MAGEE1 SHROOM2 MAP7D1 SIX5	2.93e-07	233	267	12	37704626
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	TRO BCOR POM121 CHD6 TSC22D4 WNK2 SERTAD1 PIM2 TNS2 MAGEE1 MAP7D1 SUGP2 DZIP3 SIX5 LTBP1 EGFL7 AGRN PCDH8 TP53BP2	3.01e-07	608	267	19	16713569
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	PCDHA9 AMZ1 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	3.75e-07	119	267	9	28625976
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	CDK12 SF3A1 DBN1 RREB1 BCOR USP19 TBC1D4 PNPLA6 CLUH ZNF687 SAMD4B GTSE1 NUMA1 YBX3 NIBAN2 HUWE1 RFX7 YY1 SUGP2 STC2 CTDP1	7.10e-07	774	267	21	15302935
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	PCDHA9 KDM6B SRCAP ARHGEF11 ARHGEF12 CHD9 HUWE1 SUGP2	1.48e-06	104	267	8	9205841
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A3 LRRC37A2 LRRC37A	1.78e-06	4	267	3	22419166
Pubmed	A new standard nomenclature for proteins related to Apx and Shroom.	SHROOM3 SHROOM2 SHROOM1	1.78e-06	4	267	3	16615870
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	GAK SETD1B NCF1 BCORL1 RNF40 SRCAP BCOR PTPN14 TBC1D4 ARID5B BSN ZNF574 OBSL1 TACC2 HUWE1 NOSIP GAB1	3.63e-06	588	267	17	38580884
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	ZBTB16 SOWAHC DMAP1 HOXA1 HOXD12 NR1H2 TSC22D4 FOXH1 EBF4 SERTAD1 RELA YBX3 ZBTB7B ZNF496 YY1 ASH2L BCL6B SUGP2 ZSCAN18 ZBTB3 SP7	5.01e-06	877	267	21	20211142
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZNF142 TBC1D14 CHD9 HUWE1 MTMR4 AATK RAB11FIP3	5.03e-06	87	267	7	12465718
Pubmed	Human transcription factor protein interaction networks.	BCORL1 DBN1 RREB1 SRCAP BCOR DMAP1 PRR12 GLI2 ARID5B DDX54 CHD6 ZNF687 SOBP TNIP2 NUMA1 RELA YBX3 RFX7 YY1 ASH2L NOSIP MAP7D1 ZFHX4 SUGP2 ZSCAN18 SIX5 ELK4 SP7	6.16e-06	1429	267	28	35140242
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	CDK12 SOWAHC DMAP1 TBC1D4 MTCL1 ZNF687 ZNF574 TROAP SAMD4B GTSE1 NUMA1 TACC2 NIBAN2 HUWE1 CTDP1	9.48e-06	503	267	15	16964243
Pubmed	Activation of Rac GTPase by p75 is necessary for c-jun N-terminal kinase-mediated apoptosis.	ABR ARHGEF11 PLEKHG5 VAV2 ARHGEF12	1.05e-05	38	267	5	11756498
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	BCOR MED12L FLYWCH1 HUWE1 MAGEE1 PRX HIVEP3	1.35e-05	101	267	7	10997877
Pubmed	NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway.	ABR ARHGEF11 PLEKHG5 VAV2 ARHGEF12	1.95e-05	43	267	5	12376548
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	BCORL1 RNF40 RREB1 BCOR PRR12 TBC1D4 ARID5B CHD6 ZNF687 HUWE1 MAP7D1 ZFHX4 TP53BP2	2.42e-05	418	267	13	34709266
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SF3A1 BCORL1 SRPRA RNF40 RREB1 SRCAP BCOR CASZ1 DMAP1 FANCA PRR12 ARL6IP6 ARID5B DDX54 CHD6 TET3 ZNF687 FLYWCH1 NUMA1 MUS81 RFX7 ZBTB7B YY1 ASH2L MAP7D1	2.50e-05	1294	267	25	30804502
Pubmed	Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.	DMAP1 CASKIN1 TBC1D14 ALPK3 CHD6 CRAMP1 ZNF687 EBF4	2.57e-05	153	267	8	10718198
Pubmed	Shroom2, a myosin-VIIa- and actin-binding protein, directly interacts with ZO-1 at tight junctions.	SHROOM3 SHROOM2 SHROOM1	3.63e-05	9	267	3	17666436
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	CDK12 SRPRA BCOR ARHGEF11 CASZ1 DMAP1 PRR12 PNPLA6 CHD6 PDLIM2 ZNF687 ZNF574 EEFSEC USP30 SHROOM3 FLYWCH1 SAMD4B ARHGEF12 RELA ZBTB7B ASH2L TOE1 MAP7D1 EFHD1 PLEKHG3 PALM3 AGRN	3.87e-05	1497	267	27	31527615
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	AXL DBN1 MRC2 SGSM2 SDK1 WNK2 COL4A4 TNS2 PLEKHO2	4.51e-05	214	267	9	22199357
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A3 LRRC37A2 LRRC37A	5.16e-05	10	267	3	23064749
Pubmed	Berberine suppresses the migration and invasion of colon cancer cells by inhibition of lipogenesis through modulation of promyelocytic leukemia zinc finger-mediated sterol-regulatory element binding proteins cleavage-activating protein ubiquitination.	ZBTB16 SCAP	5.87e-05	2	267	2	35641094
Pubmed	Agonist-induced Ca2+ sensitization in smooth muscle: redundancy of Rho guanine nucleotide exchange factors (RhoGEFs) and response kinetics, a caged compound study.	ARHGEF11 ARHGEF12	5.87e-05	2	267	2	24106280
Pubmed	Association of the interleukin-4 receptor alpha chain with p47phox, an activator of the phagocyte NADPH oxidase in B cells.	NCF1 IL4R	5.87e-05	2	267	2	10369419
Pubmed	APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus.	APC2 TP53BP2	5.87e-05	2	267	2	10646860
Pubmed	[Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes].	BCORL1 BCOR	5.87e-05	2	267	2	33283733
Pubmed	TET3 controls the expression of the H3K27me3 demethylase Kdm6b during neural commitment.	KDM6B TET3	5.87e-05	2	267	2	32405722
Pubmed	Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB.	NCF1 RELA	5.87e-05	2	267	2	17478731
Pubmed	Upregulated flotillins and sphingosine kinase 2 derail AXL vesicular traffic to promote epithelial-mesenchymal transition.	SPHK2 AXL	5.87e-05	2	267	2	35394045
Pubmed	Identification of receptors for pig endogenous retrovirus.	SLC52A2 SLC52A1	5.87e-05	2	267	2	12740431
Pubmed	C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.	RELA ZFTA	5.87e-05	2	267	2	25388523
Pubmed	Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.	BCORL1 BCOR	5.87e-05	2	267	2	32776737
Pubmed	Gene mutation profile in patients with acquired pure red cell aplasia.	BCORL1 BCOR	5.87e-05	2	267	2	32594217
Pubmed	Endometrial Stromal Sarcomas With BCOR Internal Tandem Duplication and Variant BCOR/BCORL1 Rearrangements Resemble High-grade Endometrial Stromal Sarcomas With Recurrent CDK4 Pathway Alterations and MDM2 Amplifications.	BCORL1 BCOR	5.87e-05	2	267	2	35499168
Pubmed	The possible involvement of tensin2 in the expression and extension of nephrin by glomerular podocytes in mice.	NPHS1 TNS2	5.87e-05	2	267	2	19129671
Pubmed	C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation.	NPHS1 TNS2	5.87e-05	2	267	2	28955049
Pubmed	C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation.	RELA ZFTA	5.87e-05	2	267	2	33685520
Pubmed	Transporters, TBC1D4, and ARID5B Variants to Explain Glycated Hemoglobin Variability in Patients with Type 2 Diabetes.	TBC1D4 ARID5B	5.87e-05	2	267	2	34265779
Pubmed	Genetic and functional analysis of SHROOM1-4 in a Chinese neural tube defect cohort.	SHROOM3 SHROOM2	5.87e-05	2	267	2	29423651
Pubmed	Riboflavin uptake transporter Slc52a2 (RFVT2) is upregulated in the mouse mammary gland during lactation.	SLC52A2 SLC52A1	5.87e-05	2	267	2	26791833
Pubmed	BCOR and BCORL1 mutations in pediatric acute myeloid leukemia.	BCORL1 BCOR	5.87e-05	2	267	2	25596268
Pubmed	Intron-less processed Pcdhalpha genes in the central nervous system.	PCDHA8 PCDHA6	5.87e-05	2	267	2	14697259
Pubmed	Trophinin and tastin, a novel cell adhesion molecule complex with potential involvement in embryo implantation.	TRO TROAP	5.87e-05	2	267	2	7758945
Pubmed	Complete Deletion of Slc52a2 Causes Embryonic Lethality in Mice.	SLC52A2 SLC52A1	5.87e-05	2	267	2	33518683
Pubmed	Verifying AXL and putative proteins as SARS-CoV-2 receptors by DnaE intein-based rapid cell-cell fusion assay.	AXL LDLRAD3	5.87e-05	2	267	2	37461287
Pubmed	BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes.	BCORL1 BCOR	5.87e-05	2	267	2	35015684
Pubmed	HSP70 mediates degradation of the p65 subunit of nuclear factor κB to inhibit inflammatory signaling.	PDLIM2 RELA	5.87e-05	2	267	2	25515536
Pubmed	BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.	BCORL1 BCOR	5.87e-05	2	267	2	24047651
Pubmed	Lipid-binding hSH3 domains in immune cell adapter proteins.	PRAM1 FYB1	5.87e-05	2	267	2	16831444
Pubmed	Involvement of riboflavin transporter RFVT2/Slc52a2 in hepatic homeostasis of riboflavin in mice.	SLC52A2 SLC52A1	5.87e-05	2	267	2	23911957
Pubmed	A role for Yin Yang-1 (YY1) in the assembly of snRNA transcription complexes.	YY1 SNAPC2	5.87e-05	2	267	2	16769183
Pubmed	Coexpression of YY1 Is Required to Elaborate the Effector Functions Controlled by PLZF in NKT Cells.	ZBTB16 YY1	5.87e-05	2	267	2	31227579
Pubmed	Supratentorial ependymomas of childhood carry C11orf95-RELA fusions leading to pathological activation of the NF-κB signaling pathway.	RELA ZFTA	5.87e-05	2	267	2	24562983
Pubmed	Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome protein CCDC8.	ARHGEF11 OBSL1 HUWE1 RFX7	6.01e-05	28	267	4	25752541
Pubmed	Fgf and Esrrb integrate epigenetic and transcriptional networks that regulate self-renewal of trophoblast stem cells.	RREB1 DMAP1 PRR12 PTPN14 ZNF687 NUMA1 ASH2L MAP7D1	7.24e-05	177	267	8	26206133
Pubmed	K48- and K63-linked ubiquitin chain interactome reveals branch- and length-specific ubiquitin interactors.	AXL USP19 GGA3 PNPLA6 PDLIM2 SHROOM3 TNIP2 GTSE1 HUWE1 SYDE1 NOSIP MAP7D1 EGFL7 FYB1 TP53BP2	7.70e-05	604	267	15	38803224
Pubmed	Protein phosphatase 1γ isoforms linked interactions in the brain.	CSRNP1 TACC2 AATK TP53BP2 PPP1R16A	7.76e-05	57	267	5	23080069
Pubmed	A negative genetic interaction map in isogenic cancer cell lines reveals cancer cell vulnerabilities.	ZNF142 RREB1 SAMD4B NUMA1 MUS81 ZNF496 LLGL2 ELK4	8.14e-05	180	267	8	24104479
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	ABR SF3A1 SRPRA ARHGEF11 PLEKHG5 ARHGAP22 VAV2 COL4A4 NUMA1 ARHGEF12 HUWE1 YY1 ASH2L SYDE1 NOSIP PLEKHG4B MLF2 MAP7D1 PLEKHG3	9.74e-05	916	267	19	32203420
Pubmed	Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR).	ABR ARHGEF11 PLEKHG5 VAV2 ARHGEF12	9.94e-05	60	267	5	12787561
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	APC2 CCDC88B AXIN1 HOXA1 ARHGAP22 WASH6P SERTAD1 TNIP2 DLGAP4 TACC2 LTBP1 SNAPC2 EGFL7 AGRN	1.24e-04	560	267	14	21653829
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	TRO SF3A1 CASZ1 DMAP1 TBC1D4 FOXH1 FLYWCH1 TNIP2 GTSE1 OBSL1 RELA HUWE1 YY1 ASH2L MAP7D1 ZFHX4 SUGP2 SIX5	1.27e-04	857	267	18	25609649
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZBTB16 HOXA1 HOXD12 GLI2 NR1H2 TSC22D4 ZNF687 SERTAD1 TACC2 ZBTB7B ASH2L ZFHX2 SIX5 ELK4 ZBTB3 SP7	1.35e-04	709	267	16	22988430
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	CDK12 SRPRA FANCA PRR12 WASH6P ZNF574 EEFSEC SAMD4B OBSL1 ASH2L SYDE1 SBNO2 MAP7D1 LLGL2 AGRN	1.72e-04	650	267	15	38777146
Pubmed	Thrombin and lysophosphatidic acid receptors utilize distinct rhoGEFs in prostate cancer cells.	ARHGEF11 ARHGEF12	1.75e-04	3	267	2	15143072
Pubmed	AXL phosphorylates and up-regulates TNS2 and its implications in IRS-1-associated metabolism in cancer cells.	AXL TNS2	1.75e-04	3	267	2	30419905
Pubmed	Histone demethylase Jmjd3 regulates osteoblast differentiation via transcription factors Runx2 and osterix.	KDM6B SP7	1.75e-04	3	267	2	24106268
Pubmed	SLC52A3, A Brown-Vialetto-van Laere syndrome candidate gene is essential for mouse development, but dispensable for motor neuron differentiation.	SLC52A2 SLC52A1	1.75e-04	3	267	2	26976849
Pubmed	Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG).	ARHGEF11 ARHGEF12	1.75e-04	3	267	2	21454492
Pubmed	The Expression of Riboflavin Transporters in Human Colorectal Cancer.	SLC52A2 SLC52A1	1.75e-04	3	267	2	29715086
Pubmed	Interaction of plexin-B1 with PDZ domain-containing Rho guanine nucleotide exchange factors.	ARHGEF11 ARHGEF12	1.75e-04	3	267	2	12220504
Pubmed	Makorin-2 is a neurogenesis inhibitor downstream of phosphatidylinositol 3-kinase/Akt (PI3K/Akt) signal.	PDLIM2 RELA	1.75e-04	3	267	2	18198183
Pubmed	Identification of two novel PCDHA9 mutations associated with Hirschsprung's disease.	PCDHA9 PCDHA12	1.75e-04	3	267	2	29477871
Interaction	TOP3B interactions	TRNP1 SPHK2 ABCA2 SETD1B ABR KIF26A CDK12 RNF40 ANKLE1 ATG2A KDM6B SRCAP FHIP1B ARHGEF11 PLEKHG5 CASZ1 GGA3 FANCA PPP1R26 PRR12 LIME1 PNPLA6 TMEM259 SGSM2 CASKIN1 SLC52A2 CRAMP1 WNK2 ZNF687 SHROOM3 SH2B3 SZT2 SAMD4B GTSE1 ZNF316 AKNA MUS81 RAPGEF1 HUWE1 EML3 SBNO2 HIVEP3 LLGL2 AATK SCAP CELSR2 SUGP2 PLEKHO2 EFHD1 TTLL4 CTDP1 AGRN IL4R PPP1R16A RAB11FIP3	5.96e-13	1470	261	55	int:TOP3B
Interaction	PCDHA10 interactions	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3	8.15e-09	22	261	7	int:PCDHA10
Interaction	P4HA3 interactions	SRCAP DMAP1 GGA3 NUTM1 MTCL1 ZNF687 SERTAD1 ZBTB7B FAM171A2 TP53BP2	2.15e-06	113	261	10	int:P4HA3
Cytoband	5q31	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	4.19e-07	115	268	8	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHA9 PROB1 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 SHROOM1	1.17e-05	298	268	10	chr5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr19q13	SPHK2 SIGLEC8 AXL SPRED3 PRR12 DNAAF3 NR1H2 ZNF541 ZNF574 SERTAD1 NPHS1 EGLN2 GRAMD1A SAMD4B PRX NOSIP ZSCAN18 SIX5	2.56e-04	1192	268	18	chr19q13
Cytoband	Ensembl 112 genes in cytogenetic band chr19p13	APC2 ANKLE1 ECSIT SHD PRAM1 PNPLA6 TMEM259 CELF5 BRME1 SYDE1 SBNO2 SUGP2 PALM3 SNAPC2	2.83e-04	797	268	14	chr19p13
GeneFamily	Clustered protocadherins	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	1.40e-07	64	169	8	20
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ABR PLEKHG5 ARHGAP22 VAV2 SH2B3 PLEKHG4B PLEKHO2 PLEKHG3 GAB1 PSD4	2.46e-05	206	169	10	682
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF142 ZBTB16 RREB1 CASZ1 GLI2 GLI4 ZNF541 ZNF574 ZNF316 ZBTB47 ZBTB7B ZNF496 YY1 HIVEP3 BCL6B ZSCAN18 ZFHX2 ZBTB3 SP7	4.36e-05	718	169	19	28
GeneFamily	PDZ domain containing	SYNPO2L ARHGEF11 PTPN4 PDLIM2 SHROOM3 ARHGEF12 SHROOM2 PRX	9.24e-05	152	169	8	1220
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ABR ARHGEF11 VAV2 ARHGEF12 PLEKHG3	3.79e-04	66	169	5	722
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	DMAP1 CHD6 CRAMP1 ZNF541	1.51e-03	53	169	4	532
GeneFamily	Ankyrin repeat domain containing	BCORL1 ANKLE1 BCOR SOWAHC CASKIN1 ANKRD34C TP53BP2 PPP1R16A	2.02e-03	242	169	8	403
GeneFamily	Immunoglobulin like domain containing	AXL ALPK3 ROBO3 SDK1 NPHS1 OBSL1 FCRLA	2.28e-03	193	169	7	594
GeneFamily	DNAJ (HSP40) heat shock proteins\|C2 tensin-type domain containing	GAK TNS2	2.34e-03	8	169	2	837
GeneFamily	INO80 complex \|SRCAP complex	SRCAP DMAP1	2.99e-03	9	169	2	1329
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL	TRNP1 TRADD AXL RTN4R ARHGAP22 PTPN14 POM121 FAM110C PRXL2C EGLN2 COL11A1 TNIP2 OBSL1 MUS81 MIEN1 NPDC1 ADAMTS8 HVCN1 ASH2L EML3 SCAP KNDC1 PODN ZFTA TMEM151A CDH3 AGRN PPP1R16A	5.49e-07	955	266	28	M45680
Coexpression	ZHONG_PFC_C3_MICROGLIA	ABCA2 APC2 RNF40 SGSM2 C1orf216 SDK1 VAV2 EBF4 MAPK8IP1 CELF5 SOBP SAMD4B NPDC1 RELA TACC2 CELSR2 KNDC1 ZFTA	2.93e-06	488	266	18	M39104
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL	TRNP1 ABCA2 BCORL1 ARHGEF11 CASZ1 MGAT3 SDK1 PRXL2C WNK2 VGF MAPK8IP1 SOBP NPDC1 SLC4A3 ZFHX2 ZFTA	9.16e-06	429	266	16	M45694
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL	TRNP1 TRADD AXL ARHGAP22 LIME1 CSRNP1 PTPN14 FAM110C SHROOM3 COL11A1 OBSL1 MUS81 MIEN1 NPDC1 EML3 PLEKHG3 PODN TMEM151A CDH3 AGRN PPP1R16A	1.18e-05	704	266	21	M45672
Coexpression	LIM_MAMMARY_LUMINAL_MATURE_UP	CASZ1 DNAAF3 WNK4 FBXO36 PLEKHG3 ZSCAN18 ZFHX2 PSD4	1.94e-05	112	266	8	MM1327
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN	SPHK2 GAK ZNF142 ABR NCF1 ATG2A CASZ1 ITIH4 AXIN1 DMAP1 GGA3 PRAM1 PRR14 PNPLA6 TMEM259 SGSM2 GRAMD1A RAPGEF1 NIBAN2 EML3 MAP7D1 SCAP SUGP2 ZSCAN18	1.95e-05	905	266	24	M40865
Coexpression	LIM_MAMMARY_LUMINAL_MATURE_UP	CASZ1 DNAAF3 WNK4 FBXO36 PLEKHG3 ZSCAN18 ZFHX2 PSD4	2.07e-05	113	266	8	M2578
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	ABR APC2 ADARB2 CASZ1 CASKIN1 BSN VAV2 ADGRL3 VGF CELF5 COL11A1 SOBP ARHGEF12 NPDC1 RFX7 SHROOM2 SLC4A3 HIVEP3 PIANP AATK ZFHX4 SUGP2 ZFHX2 TMEM151A LONRF2 VPS53 PCDH8	2.50e-05	1106	266	27	M39071
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	SPHK2 GAK SETD1B ABR NCF1 ATG2A CASZ1 AXIN1 DMAP1 GGA3 PNPLA6 SGSM2 GRAMD1A NIBAN2 EML3 MAP7D1 SCAP SUGP2 ZSCAN18	2.92e-05	634	266	19	M40866
Coexpression	BHAT_ESR1_TARGETS_VIA_AKT1_UP	AMZ1 AXIN1 CLUH VGF AKNA CHD9 TOE1 SBNO2 CELSR2 STC2 LONRF2 RAB11FIP3	3.33e-05	281	266	12	M2234
Coexpression	GSE39556_CD8A_DC_VS_NK_CELL_DN	PPP1R26 MIA2 MTCL1 PIM2 SH2B3 CTDP1 DZIP3 SNAPC2 IL4R PSD4	3.73e-05	198	266	10	M9407
Coexpression	GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN	PDE4B RREB1 AXIN1 MAPK8IP1 PIM2 HUWE1 CTDP1 SIX5 ELK4 IL4R	3.89e-05	199	266	10	M9031
Coexpression	GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN	SRCAP USP19 AXIN1 TBC1D4 TBC1D14 TSC22D4 PRXL2C FCRLA SLC4A3 PIANP	4.06e-05	200	266	10	M4667
Coexpression	GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN	KDM6B ARMCX2 GLI2 C1orf216 SLC52A2 ARHGEF12 FBXO36 ARR3 PLEKHO2 CTDP1	4.06e-05	200	266	10	M8496
Coexpression	GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN	ZBTB16 AXL OTUD1 SYNPO2L CDHR5 KDM6B ARMCX2 SOWAHC CSRNP1 AGRN	4.06e-05	200	266	10	M9839
Coexpression	GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP	AMZ1 BCORL1 PTPN4 MRC2 CASKIN1 PRXL2C WNK4 EBF4 PIM2 LLGL2	4.06e-05	200	266	10	M8703
Coexpression	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	TRNP1 CASZ1 WNK2 VGF ADAMTS2 ADAMTS8 PLEKHG3 KNDC1 PODN PCDH8	6.12e-05	210	266	10	M2010
Coexpression	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	TRNP1 CASZ1 WNK2 VGF ADAMTS2 ADAMTS8 PLEKHG3 KNDC1 PODN PCDH8	8.05e-05	217	266	10	MM861
Coexpression	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN	SPHK2 SETD1B ATG2A PRR14 PNPLA6 SH2B3 GRAMD1A ATF6B	9.07e-05	139	266	8	M8948
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	TRNP1 CASZ1 STAC PTPN14 GLI2 FAM110C PDLIM2 WNK4 VAV2 EBF4 VGF SHROOM3 ADAMTS2 ADAMTS8 ZBTB7B SHROOM1 LLGL2 EFHD1 PLEKHG3 PODN INAVA PCDH8 IL4R SNX22 GAB1	1.07e-04	1074	266	25	M1941
Coexpression	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	ABCA2 ABR ATG2A DBN1 FANCA PNPLA6 C1orf216 PIM2 OBSL1 CELSR2 AGRN	1.30e-04	276	266	11	M3063
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	AXL TRO PLEKHG5 ARHGAP22 OLFML2A MRC2 ZBTB47 ADAMTS8 HVCN1 SYDE1 PLEKHO2	3.03e-08	195	268	11	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PCDHA9 LRRC37A MRC2 CASKIN1 WNK4 ADGRL3 COL11A1 PCDHA12 ZFHX4 EFHD1 PCDH8	3.73e-08	199	268	11	45c3b853900d8c3d5965117d904e3714100138bc
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABR AXL NCF1 KIF12 SOWAHC CCDC88B ZNF316 SLC4A3 AATK CELSR2	1.21e-07	176	268	10	5e46a09a36b9645b1b1fcb0b64bd0898561af3a9
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LDLRAD3 MRC2 ARID5B SDK1 ADAMTS2 SOBP ADAMTS8 SBNO2 HIVEP3 STC2	2.59e-07	191	268	10	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	Adult-Immune\|Adult / Lineage, Cell type, age group and donor	PDE4B ABR LDLRAD3 STAC PRAM1 PNPLA6 SH2B3 RAPGEF1 TYMP FYB1	3.61e-07	198	268	10	9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PCDHA9 MRC2 CASKIN1 COL11A1 PCDHA12 ZFHX4 SIX5 PCDH8 GAB1 RAB11FIP3	3.78e-07	199	268	10	a13f4b8a039304e685464cc8879659824cad5a3e
ToppCell	droplet-Lung-LUNG-1m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FANCA ARHGAP22 DNAAF3 TBC1D4 TIPIN SH2B3 PIANP EFHD1 SNX22	8.14e-07	167	268	9	e30e7ac8ea4399dc3c1d94fc6b857afc80a7a671
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KDM6B LDLRAD3 SHD PTPN14 ALKBH8 ADGRL3 CELF5 EGLN2 AKNA	8.99e-07	169	268	9	7cb1b87be66a22fe5731bb1b55bc515920fe3e8b
ToppCell	E18.5-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF142 MGAT3 MED12L CRAMP1 WNK2 FBXO36 SBNO2 CELSR2 STC2	1.04e-06	172	268	9	1bbf5ed7d13635f9a7e528060341e0652699bd7c
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYOM1 AXL STAC OLFML2A TROAP GTSE1 C4orf54 EFHD1 PLEKHG3	1.82e-06	184	268	9	d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE4B KDM6B CSRNP1 PTPN14 SAMD4B YBX3 CELSR2 INAVA CDH3	1.99e-06	186	268	9	bd1185592aedebccd1007dbf2dd2f549fcdf9f42
ToppCell	P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYOM1 AXL STAC ITIH4 OLFML2A SHROOM3 ADAMTS2 PLEKHG3 CDH3	2.17e-06	188	268	9	6ec22b79b19d57ea187f312907819dc2d01f3efe
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Epithelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE4B KDM6B CSRNP1 PTPN14 SAMD4B YBX3 CELSR2 INAVA CDH3	2.27e-06	189	268	9	965e0e388251e7318f8b463816dc96ccb4658677
ToppCell	Control-B_naive-13\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	OTUD1 NCF1 KDM6B CSRNP1 SERTAD1 YBX3 FCRLA HVCN1 IL4R	2.70e-06	193	268	9	32e53a6473a682cf14b20a399c3686f658298b93
ToppCell	wk_08-11-Hematologic-Myeloid-Myelocyte-like\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	NCF1 PRAM1 TIPIN BRME1 AKNA ZBTB47 TYMP GAB1 PSD4	3.06e-06	196	268	9	4b88c96b737a747422674ad99c073b28e6febc7c
ToppCell	Healthy_donor-B_naive\|Healthy_donor / disease group, cell group and cell class (v2)	PDE4B NCF1 PIM2 YBX3 FCRLA HVCN1 ZSCAN18 IL4R SNX22	3.06e-06	196	268	9	cf254b1466357984201595fa32408d659eb741ef
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRNP1 ARID5B NPHS1 NPDC1 EFHD1 TMEM151A MYO15A CDH3 PPP1R16A	3.06e-06	196	268	9	8c8a73d9d9581b8d9a9babfa93459d12fb9eb3ac
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRNP1 ARID5B NPHS1 NPDC1 EFHD1 TMEM151A MYO15A CDH3 PPP1R16A	3.06e-06	196	268	9	429de4119c8b2193c992d36a6af84f806730cbee
ToppCell	Healthy/Control-B_naive\|Healthy/Control / Disease group and Cell class	PDE4B NCF1 PIM2 YBX3 FCRLA HVCN1 ZSCAN18 IL4R SNX22	3.06e-06	196	268	9	e92d2c814d2dcb049f3e455fe66fd40898b3524d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AXL IRAG1 LDLRAD3 MRC2 GLI2 ADGRL3 ADAMTS2 FMNL3 LTBP1	3.06e-06	196	268	9	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AXL IRAG1 LDLRAD3 MRC2 GLI2 ADGRL3 ADAMTS2 FMNL3 LTBP1	3.06e-06	196	268	9	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4B ABR NCF1 CCDC88B ARHGAP22 PRAM1 SH2B3 AKNA FYB1	3.06e-06	196	268	9	291c59b609985167c98a40d4e2caeea2fad74941
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PDE4B STAC FANCA ARHGAP22 PNPLA6 TROAP GTSE1 BRME1 TOE1	3.19e-06	197	268	9	d669d90c3f9e98b41bcbc49dbdc5698e0b42597c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4B ABR NCF1 CCDC88B ARHGAP22 PRAM1 SH2B3 AKNA FYB1	3.19e-06	197	268	9	826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG\|World / Primary Cells by Cluster	CSRNP1 MRC2 SHROOM3 COL11A1 YBX3 ZFHX4 EFHD1 LTBP1 GAB1	3.19e-06	197	268	9	61749ccafeb938c310cff1de5ff924a1c794325a
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|lung / Disease (COVID-19 only), tissue and cell type	PDE4B ABR NCF1 ARHGAP22 PRAM1 TBC1D14 TET3 TYMP FYB1	3.19e-06	197	268	9	3896729740d151f0eb845f1961c7b969bfbdd28d
ToppCell	Non-neuronal-Non-dividing-Radial_Glia-tRG-25\|World / Primary Cells by Cluster	CSRNP1 MRC2 SHROOM3 COL11A1 YBX3 ZFHX4 EFHD1 LTBP1 GAB1	3.19e-06	197	268	9	9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA2 GPR62 PDLIM2 MAPK8IP1 AATK EFHD1 KNDC1 TMEM151A GAB1	3.46e-06	199	268	9	67d8c7e5356f5d409d4f98e8338cf6c499fd7aee
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA2 GPR62 TSC22D4 PDLIM2 MAPK8IP1 AATK EFHD1 KNDC1 TMEM151A	3.61e-06	200	268	9	0e85c90719d9ec51a566e230c9dd2909d8df1f52
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA2 GPR62 TSC22D4 MAPK8IP1 AATK EFHD1 KNDC1 TMEM151A GAB1	3.61e-06	200	268	9	56f1f007ba8c9188a4b10e52744f1e50dc0f155a
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	RREB1 IRAG1 CCDC88B OLFML2A MRC2 ZBTB7B HVCN1 SYDE1 IL4R	3.61e-06	200	268	9	25f4c051c2e869481f33c22ad54de97efac444ad
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	KDM6B OLFML2A WNK2 VGF CELF5 SOBP MTMR4 CELSR2 ZFHX4	3.61e-06	200	268	9	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	LRRC37A2 AXIN1 GLI4 FAM110C RFX7 SYDE1 FMNL3 LLGL2 MYO15A	3.61e-06	200	268	9	0f4b8b0868bda406fe6bf01d1b722510fdfd0168
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	RREB1 IRAG1 CCDC88B OLFML2A MRC2 ZBTB7B HVCN1 SYDE1 IL4R	3.61e-06	200	268	9	da45a85a4667965b24ba824af871157af5b4cd19
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA2 GPR62 PDLIM2 MAPK8IP1 AATK EFHD1 KNDC1 TMEM151A GAB1	3.61e-06	200	268	9	e5b4821fff40566c4a7dc3f74a14e27eb06b165d
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Macroglial\|3m / Sample Type, Dataset, Time_group, and Cell type.	MRC2 TSC22D4 PDLIM2 COL11A1 OBSL1 YBX3 ZFHX4 STC2 LTBP1	3.61e-06	200	268	9	38b51f337e183011e3ff32997ec26d8a424c6b78
ToppCell	droplet-Lung-nan-21m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATG2A LDLRAD3 SOWAHC STAC SPRED3 DNAAF3 OLFML2A PLEKHO2	5.83e-06	160	268	8	4738d0c73d8c3508e5b5beb6c61e0ad551d9b949
ToppCell	droplet-Lung-nan-21m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATG2A LDLRAD3 SOWAHC STAC SPRED3 DNAAF3 OLFML2A PLEKHO2	5.83e-06	160	268	8	0b8151037b28f52a21918856a1e9336e8d5edb90
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Myeloid-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCDC88B STAC PRAM1 MED12L FAM110C WNK2 GTSE1 RAB44	8.72e-06	169	268	8	bca5322880c09b78ef10d9dda6420a80c1ba7e62
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_1\|356C / Donor, Lineage, Cell class and subclass (all cells)	LRRC37A2 SRCAP PRR12 TBC1D4 ARID5B PIM2 RTL10 NPDC1	1.03e-05	173	268	8	e3cb7c8c09f937da6b8d673e9adfec5d94a15548
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYOM1 SYNPO2L STAC OLFML2A TIPIN C4orf54 PIANP PPP1R16A	1.08e-05	174	268	8	9f2e253694eb5860c00528fda31c305c6de8a2a1
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	COL4A4 CELF5 AATK PALM3 INAVA CDH3 AGRN SNX22	1.08e-05	174	268	8	edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)\|367C / Donor, Lineage, Cell class and subclass (all cells)	COL4A4 CELF5 AATK PALM3 INAVA CDH3 AGRN SNX22	1.08e-05	174	268	8	65539f69100db0b7d90b1b39ee15ab8281f86461
ToppCell	droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMZ1 DBN1 ARHGAP22 TBC1D4 MED12L FCRLA PIANP SNX22	1.08e-05	174	268	8	2afa5eea54b67c549c5058ece98296eee3829c11
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABR AXL KIF12 SOWAHC CCDC88B ZNF316 SLC4A3 AATK	1.22e-05	177	268	8	14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ABCA2 CDHR5 ZNF687 COL11A1 PLEKHG4B ZFHX4 LONRF2	1.26e-05	128	268	7	2cf0384240a4a663869cf6b27d954236f6214a9a
ToppCell	facs-Lung-EPCAM-3m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AMZ1 NCF1 IRAG1 CCDC88B TBC1D4 FCRLA PIANP SNX22	1.27e-05	178	268	8	8c5e9fab7b55a654ccaabf2c4d02397399d94616
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYOM1 ANKLE1 ITIH4 SPRED3 FAM110C WNK4 COL4A4 SHROOM1	1.32e-05	179	268	8	ca70a5518c5a5392e088c103e0cb44aa084f5332
ToppCell	droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYOM1 ANKLE1 ITIH4 SPRED3 FAM110C WNK4 COL4A4 SHROOM1	1.32e-05	179	268	8	c451b074b04eb5d6c575c6abaedda579c6744bbf
ToppCell	droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D4 WNK4 ADGRL3 WNK2 ZNF316 PRX CELSR2 RASGEF1C	1.49e-05	182	268	8	c00e503f442d44fbae73c5e2dc85be69e294e67a
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AXL ANKLE1 SOWAHC FAM110C TROAP GTSE1 TACC2 EFHD1	1.55e-05	183	268	8	e91f00b75d43ee6293fdd4a129b789cd95f8d11a
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MGAT3 PDLIM2 COL4A4 ZBTB47 MAP7D1 AATK AGRN SNX22	1.62e-05	184	268	8	c7073d1b2c4fdb154d87678b92a0629c02116972
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	MGAT3 PDLIM2 COL4A4 ZBTB47 MAP7D1 AATK AGRN SNX22	1.62e-05	184	268	8	1ed558a88215b248431c524ea16f13d9022ae98c
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB16 MYOM1 IRAG1 LDLRAD3 GLI2 ADGRL3 TNS2 LTBP1	1.68e-05	185	268	8	51dfe6ac7df8b330343b37e3bee71e5c65267189
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB16 MYOM1 IRAG1 LDLRAD3 GLI2 ADGRL3 TNS2 LTBP1	1.68e-05	185	268	8	a8c02cec3c414f3a0da9f2d6d28ce563b0030705
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ABCA2 ZBTB16 FHIP1B LRRC47 FANCA MUS81 FMNL3 MTMR4	1.75e-05	186	268	8	927723ad579bbd9947ff525bd501e222d3fa9289
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	AXL DBN1 ARMCX2 COL4A4 SOBP EFHD1 ZFTA TMEM151A	1.82e-05	187	268	8	fa8f221b4c2df61eadaa9c77e4cf45848b00330b
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-naive_B_cell\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PDE4B NCF1 YBX3 FCRLA HVCN1 IL4R SNX22 GAB1	1.82e-05	187	268	8	160e5f338537d90d50f863a1be801b1071ac7da7
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 AXL IRAG1 LDLRAD3 GLI2 ADGRL3 WNK2 LTBP1	1.89e-05	188	268	8	b2d68a32314e9b099ed74d974079ad96359d1ae3
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	GLI2 ZBTB47 RAB44 FMNL3 BCL6B SHROOM1 SIX5 PODN	1.89e-05	188	268	8	c90669b51e1902fe7726555290c91c92a911df83
ToppCell	Adult\|World / Lineage, Cell type, age group and donor	ABR CASZ1 ARHGAP22 RAPGEF1 TACC2 TYMP LLGL2 KNDC1	1.96e-05	189	268	8	5cd285bfad973125d46d704fec18b21266a63379
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB16 MYOM1 IRAG1 GLI2 SDK1 ADGRL3 WNK2 LTBP1	1.96e-05	189	268	8	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB16 MYOM1 IRAG1 GLI2 SDK1 ADGRL3 WNK2 LTBP1	1.96e-05	189	268	8	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Naive_B_cells\|bone_marrow / Manually curated celltypes from each tissue	NCF1 SOBP YBX3 FCRLA HVCN1 IL4R SNX22 GAB1	2.04e-05	190	268	8	3d45d5011305f13634013d9eeb98f235517dd54e
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYOM1 AXL IRAG1 STAC ITIH4 OLFML2A ADAMTS2 PLEKHG3	2.04e-05	190	268	8	7df63e5e0dd395676f4fc18cad0d8b2428390943
ToppCell	Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PDE4B NCF1 YBX3 FCRLA HVCN1 IL4R SNX22 GAB1	2.11e-05	191	268	8	3fc16e986aff5e0cd4f831e25e78a5b30beba7a8
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 AXL IRAG1 GLI2 SDK1 ADGRL3 WNK2 LTBP1	2.20e-05	192	268	8	bfab13793e54de2550ee171397f7ece0625cdb4a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYOM1 AXL IRAG1 GLI2 SDK1 ADGRL3 WNK2 LTBP1	2.20e-05	192	268	8	b54b0d5b88139905521c8d5d58332e89c08d589c
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CSRNP1 MRC2 ZNF541 RAPGEF1 YBX3 HVCN1 PRX LTBP1	2.20e-05	192	268	8	aedddccacf60e884af044cefba6c64ca10ac97d2
ToppCell	368C-Endothelial_cells-Endothelial-B_(Artery)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CSRNP1 MRC2 ZNF541 RAPGEF1 YBX3 HVCN1 PRX LTBP1	2.20e-05	192	268	8	389d5e6d0689371bfe1d0b06e92e0e6e5573567b
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYOM1 AXL IRAG1 STAC ITIH4 OLFML2A ADAMTS2 LTBP1	2.20e-05	192	268	8	26d9207e72bbef5e0046de511e2c9ff752b726f3
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B-Naive_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	OTUD1 NCF1 SOBP YBX3 FCRLA HVCN1 IL4R GAB1	2.28e-05	193	268	8	eb497d62a45ad77b2578b03a84cb3edc83207be5
ToppCell	Parenchymal-NucSeq-Stromal-Chondrocytic-Chondrocyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRO LDLRAD3 NUTM1 COL11A1 ZNF316 SYDE1 PIWIL3 SP7	2.28e-05	193	268	8	ab36d684bde8fe77d11a5188425135328052c58b
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYOM1 TRO SYNPO2L IRAG1 STAC OLFML2A ADAMTS2 PLEKHG3	2.28e-05	193	268	8	469a7f1c2ff7137cc5a064464456911f67f92e70
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYOM1 AXL IRAG1 STAC ITIH4 OLFML2A ADAMTS2 PLEKHG3	2.28e-05	193	268	8	7fc3ab7261c88c1df71744bf5b17e8e46c4300e0
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZBTB16 GLI2 SDK1 VAV2 ADAMTS2 ADAMTS8 HIVEP3 LTBP1	2.28e-05	193	268	8	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	10x5'v1-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	ADGRL3 ADAMTS2 NPDC1 TACC2 PIANP ZFHX4 EFHD1 PODN	2.28e-05	193	268	8	3d85c28f6ebdcb15e875ad01d52d6c138fbf8525
ToppCell	Parenchymal-NucSeq-Stromal-Chondrocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRO LDLRAD3 NUTM1 COL11A1 ZNF316 SYDE1 PIWIL3 SP7	2.28e-05	193	268	8	df4afb4848eb9d7d8d39e5c612919663cbbb2514
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-Naive_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	OTUD1 NCF1 YBX3 FCRLA HVCN1 IL4R SNX22 GAB1	2.36e-05	194	268	8	20967afbadb3cf80ba9f4d7ebda4e64389252e70
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	OTUD1 NCF1 ARID5B VAV2 RAPGEF1 FCRLA HVCN1 SNX22	2.36e-05	194	268	8	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	control-Lymphoid-B_cell\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PDE4B NCF1 KDM6B ARID5B VAV2 FCRLA HVCN1 SNX22	2.36e-05	194	268	8	a5284adca931a78b1c4592925c4860853ebd24f1
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231\|Adult / Lineage, Cell type, age group and donor	ABR ARHGAP22 TBC1D14 VAV2 SH2B3 RAPGEF1 TYMP FYB1	2.36e-05	194	268	8	800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IRAG1 MRC2 GLI2 ADGRL3 COL11A1 ADAMTS2 ZFHX4 LTBP1	2.45e-05	195	268	8	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	Mesenchymal_cells-Endosteal_fibro.\|World / Lineage and Cell class	TRNP1 AXL DBN1 OLFML2A SDK1 PDLIM2 NPDC1 EFHD1	2.45e-05	195	268	8	d53974d1866e23c894ffd492ea11d20422919b11
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PDE4B NCF1 CCDC88B ARHGAP22 SH2B3 AKNA TYMP FYB1	2.45e-05	195	268	8	09df40ff9b493170861b3f6e57a942a834655b5c
ToppCell	TCGA-Thryoid-Primary_Tumor\|TCGA-Thryoid / Sample_Type by Project: Shred V9	ABR MRC2 GRAMD1A DLGAP4 NPDC1 SNAPC2 CDH3 AGRN	2.45e-05	195	268	8	7cdee2ae90edf15e4cbcf70797b8caf1f037b0ef
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma\|TCGA-Thryoid / Sample_Type by Project: Shred V9	ABR MRC2 GRAMD1A DLGAP4 NPDC1 SNAPC2 CDH3 AGRN	2.45e-05	195	268	8	b61b8c931bd0ca3678486653ae1d7e9915c696c7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	IRAG1 MRC2 GLI2 ADGRL3 COL11A1 ADAMTS2 ZFHX4 LTBP1	2.45e-05	195	268	8	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ABCA2 ZBTB16 ATG2A DBN1 PTPN4 AKNA NPDC1 LLGL2	2.54e-05	196	268	8	aec2b11a6048048820271266fdc8b8d806da9993
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB16 MYOM1 AXL IRAG1 GLI2 ADGRL3 WNK2 LTBP1	2.54e-05	196	268	8	1522958a92e0126326a9f0d9fb1c5b5c50b001ea
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ABCA2 ZBTB16 ATG2A DBN1 PTPN4 AKNA NPDC1 LLGL2	2.54e-05	196	268	8	aa0dc04f94a575cd442ee473b75a4f54268e4105
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZBTB16 IRAG1 ADGRL3 TNS2 ADAMTS8 SYDE1 EFHD1 LTBP1	2.54e-05	196	268	8	f78951b460913866d092ba92af70ea76a2afa73e
ToppCell	COVID-19-Myeloid-Transitioning_MDM\|COVID-19 / group, cell type (main and fine annotations)	PDE4B ABR RREB1 LDLRAD3 TBC1D14 RAPGEF1 TYMP FYB1	2.54e-05	196	268	8	4929cfed1f150c1fde4d79cb49895c2ea467a18f
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA2 ZBTB16 ATG2A DBN1 PTPN4 AKNA NPDC1 LLGL2	2.54e-05	196	268	8	ae9bf04531b9bda819608d90736c4405a6c3df41
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZBTB16 MRC2 GLI2 SDK1 ADAMTS2 ADAMTS8 PODN LTBP1	2.54e-05	196	268	8	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB16 MYOM1 AXL IRAG1 GLI2 ADGRL3 WNK2 LTBP1	2.54e-05	196	268	8	1c8294014713684b50885e638668f2ce75f357f0
ToppCell	3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZBTB16 IRAG1 ADGRL3 TNS2 ADAMTS8 SYDE1 EFHD1 LTBP1	2.54e-05	196	268	8	4da96672a9c72268cfcc82d61eb3caae6e02d4c4
ToppCell	metastatic_Brain-Myeloid_cells-CD163+CD14+_DCs\|metastatic_Brain / Location, Cell class and cell subclass	PDE4B AXL OTUD1 KDM6B PRAM1 CSRNP1 SH2B3 TYMP	2.54e-05	196	268	8	3cd96d5729b7030ba57f21f5231096d93ef30e56
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ABCA2 ZBTB16 ATG2A DBN1 PTPN4 AKNA NPDC1 LLGL2	2.54e-05	196	268	8	502834a16d5ada93af7ab9af0c3dc652086964bd
ToppCell	Healthy/Control-B_naive\|World / Disease group and Cell class	PDE4B PIM2 YBX3 FCRLA HVCN1 ZSCAN18 IL4R SNX22	2.54e-05	196	268	8	ec935a4e16495c87b17070eb13c1e28bdb64e7ee
Drug	DAPH; Up 200; 10uM; PC3; HG-U133A	ABCA2 ZNF142 KDM6B SRCAP STAC TBC1D4 MRC2 DDX54 TNS2 NPDC1 CELSR2 CTDP1 CDH3 IL4R TP53BP2	1.13e-08	199	262	15	578_UP
Drug	Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; PC3; HT_HG-U133A	SPHK2 PDE4B STAC MRC2 SGSM2 TSC22D4 PDLIM2 ADGRL3 SOBP OBSL1 CELSR2 ZFHX2 FYB1	4.79e-07	196	262	13	4580_DN
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	SPHK2 ABCA2 PTPN14 MGAT3 MIA2 VGF PCDHA6 YY1 CELSR2 ELK4 EGFL7 IL4R RAB11FIP3	5.08e-07	197	262	13	1635_UP
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	SPHK2 BCORL1 ARHGEF11 PNPLA6 CLUH VGF NUMA1 OBSL1 SCAP CTDP1 EGFL7 AGRN	2.61e-06	193	262	12	3262_UP
Drug	Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; MCF7; HT_HG-U133A	SOWAHC AXIN1 GGA3 PNPLA6 TMEM259 SLC52A1 PIM2 SH2B3 SZT2 PCDHA5 PLEKHG3 RAB11FIP3	2.91e-06	195	262	12	7037_UP
Drug	Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ABCA2 BCOR ARHGEF11 C1orf216 VGF SH2B3 EML3 SUGP2 PLEKHO2 PLEKHG3 CTDP1 ZBTB3	3.78e-06	200	262	12	2652_DN
Drug	0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A	ZNF142 SETD1B RREB1 AXIN1 ARID5B MTCL1 CHD9 TACC2 SBNO2 DNAAF2 ZBTB3	8.97e-06	182	262	11	3630_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA	BCORL1 DBN1 ARMCX2 HOXA1 OLFML2A VGF SH2B3 SOBP PCDHA5 ZFHX2 IL4R	1.28e-05	189	262	11	989_UP
Drug	Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A	BCORL1 ATG2A SGSM2 VGF NUMA1 RTL10 PCDHA6 RELA SHROOM2 SYDE1 AGRN	1.56e-05	193	262	11	7033_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A	FANCA NR1H2 ZNF574 EGLN2 DLGAP4 NUMA1 EML3 HIVEP3 PLEKHO2 ELK4 RAB11FIP3	1.64e-05	194	262	11	1223_DN
Drug	W-13, hydrochloride; Up 200; 10uM; MCF7; HG-U133A	ABCA2 SRPRA TMEM259 SLC52A2 NUMA1 OBSL1 SBNO2 LLGL2 EGFL7 FYB1 AGRN	1.64e-05	194	262	11	440_UP
Drug	2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A	DBN1 OLFML2A MGAT3 TBC1D4 PNPLA6 SGSM2 MTCL1 SOBP DLGAP4 NUMA1 IL4R	1.72e-05	195	262	11	6999_UP
Drug	Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A	SPHK2 ATG2A DBN1 AXIN1 PIM2 SZT2 NUMA1 OBSL1 SCAP CELSR2 PSD4	1.72e-05	195	262	11	3278_UP
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; HL60; HG-U133A	DBN1 KDM6B ARHGEF11 STAC FANCA PDLIM2 TNIP2 SYDE1 AATK STC2 RAB11FIP3	1.72e-05	195	262	11	1371_DN
Drug	Sulfacetamide sodic hydrate [6209-17-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A	BCORL1 SRPRA KDM6B BCOR TMEM259 PDLIM2 VAV2 ZNF574 VGF DZIP3 RAB11FIP3	1.80e-05	196	262	11	1695_DN
Drug	resveratrol; Down 200; 50uM; PC3; HG-U133A	CDK12 AXIN1 GLI2 SZT2 GTSE1 ARHGEF12 TOE1 PRX LLGL2 TTLL4 RAB11FIP3	1.89e-05	197	262	11	662_DN
Drug	Clozapine [5786-21-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A	SPHK2 STAC VAV2 SLC52A1 DLGAP4 NUMA1 SYDE1 AATK ZFHX2 EGFL7 GAB1	1.89e-05	197	262	11	5630_UP
Drug	Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; HL60; HG-U133A	TRADD GAK ZNF142 SETD1B CASZ1 SH2B3 GTSE1 ARHGEF12 EML3 SUGP2 PSD4	1.89e-05	197	262	11	1577_DN
Drug	(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; HL60; HT_HG-U133A	CASZ1 MGAT3 TMEM259 VGF CABP2 PCDHA5 HUWE1 YY1 ZFHX4 SUGP2 LTBP1	1.98e-05	198	262	11	3067_UP
Drug	Sulfasalazine [599-79-1]; Down 200; 10uM; PC3; HT_HG-U133A	ABR KDM6B TBC1D4 SGSM2 DDX54 TNS2 SHROOM2 EML3 CELSR2 SNAPC2 CDH3	1.98e-05	198	262	11	6346_DN
Drug	Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; MCF7; HT_HG-U133A	ABCA2 SIGLEC8 STAC FANCA OLFML2A PNPLA6 OBSL1 RAPGEF1 ZFHX4 PLEKHO2 PSD4	2.07e-05	199	262	11	6783_UP
Drug	wortmannin; Down 200; 0.01uM; ssMCF7; HG-U133A	KDM6B PPP1R26 OLFML2A CHD9 SBNO2 AATK SUGP2 ZFHX2 LTBP1 ELK4 RAB11FIP3	2.07e-05	199	262	11	404_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A	ABCA2 SOWAHC TBC1D4 PNPLA6 DDX54 MTCL1 DLGAP4 YY1 SBNO2 PLEKHG3 TP53BP2	2.07e-05	199	262	11	6942_DN
Drug	Netilmicin sulfate [56931-57-2]; Up 200; 2.8uM; HL60; HT_HG-U133A	TRADD HOXA1 MIA2 PDLIM2 SOBP YY1 EML3 ZFHX4 ELK4 VPS53 AGRN	2.17e-05	200	262	11	2963_UP
Drug	clozapine; Down 200; 10uM; MCF7; HT_HG-U133A	SRCAP ARHGEF11 DDX54 MTCL1 ZNF574 VGF DLGAP4 RTL10 ARHGEF12 YY1 ELK4	2.17e-05	200	262	11	6947_DN
Drug	2-propylpentanoic acid; Down 200; 10000uM; MCF7; HG-U133A	ZNF142 SETD1B AXIN1 DLGAP4 OBSL1 SBNO2 HIVEP3 STC2 CDH3 AGRN	6.80e-05	188	262	10	345_DN
Drug	Triamcinolone [124-94-7]; Up 200; 10.2uM; PC3; HT_HG-U133A	SPHK2 PDE4B BCORL1 RREB1 CASZ1 NUMA1 RTL10 AATK ZFHX2 ELK4	8.47e-05	193	262	10	2078_UP
Drug	Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; PC3; HT_HG-U133A	SPHK2 PDE4B KDM6B ARHGAP22 VAV2 NUMA1 PCDHA6 TTLL4 EGFL7 FYB1	8.84e-05	194	262	10	4506_UP
Drug	Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ARHGEF11 MIA2 SGSM2 TSC22D4 VGF TNS2 EML3 SYDE1 PLEKHO2 ELK4	8.84e-05	194	262	10	3194_DN
Drug	Idoxuridine [54-42-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A	PCDHA9 USP19 OLFML2A DDX54 SBNO2 SUGP2 PLEKHG3 CTDP1 LTBP1 RAB11FIP3	8.84e-05	194	262	10	1480_DN
Drug	Isradipine [75695-93-1]; Down 200; 10.8uM; PC3; HT_HG-U133A	GAK ABR TBC1D4 SGSM2 NR1H2 PDLIM2 ZNF574 HIVEP3 CELSR2 CDH3	8.84e-05	194	262	10	6347_DN
Drug	Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A	ARHGEF11 TMEM259 ZNF574 VGF TNS2 PCDHA6 YY1 SBNO2 CTDP1 SNAPC2	9.22e-05	195	262	10	5399_DN
Drug	Megestrol acetate [595-33-5]; Up 200; 10.4uM; HL60; HT_HG-U133A	ABR SRPRA OLFML2A MGAT3 MRC2 CABP2 OBSL1 HUWE1 SNAPC2 RAB11FIP3	9.22e-05	195	262	10	3091_UP
Drug	Quinacrine dihydrochloride dihydrate [6151-30-0]; Down 200; 7.8uM; MCF7; HT_HG-U133A	ABR MIA2 VAV2 YY1 PLEKHO2 TTLL4 CTDP1 DZIP3 ELK4 SNAPC2	9.22e-05	195	262	10	3179_DN
Drug	SC 19220; Up 200; 10uM; MCF7; HT_HG-U133A	USP19 AXIN1 FANCA PTPN14 DDX54 SZT2 SYDE1 PLEKHO2 VPS53 IL4R	9.22e-05	195	262	10	7060_UP
Drug	Epitiostanol [2363-58-8]; Down 200; 13uM; HL60; HT_HG-U133A	TRADD BCORL1 SRCAP USP19 HOXA1 EML3 DNAAF2 PLEKHG3 DZIP3 AGRN	9.62e-05	196	262	10	2922_DN
Drug	Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; HL60; HT_HG-U133A	ARHGEF11 AXIN1 MRC2 ADGRL3 SZT2 YY1 SYDE1 FYB1 AGRN PSD4	9.62e-05	196	262	10	2473_DN
Drug	Cyclobenzaprine hydrochloride [6202-23-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A	CASZ1 FANCA PNPLA6 TMEM259 VGF ARHGEF12 EML3 TTLL4 CTDP1 EGFL7	9.62e-05	196	262	10	4834_DN
Drug	Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A	OLFML2A PNPLA6 VAV2 SH2B3 GTSE1 YY1 SBNO2 TTLL4 CTDP1 RAB11FIP3	9.62e-05	196	262	10	1474_DN
Drug	radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; PC3; HT_HG-U133A	KDM6B GLI2 OBSL1 HUWE1 PLEKHG3 ZFHX2 MYO15A FYB1 VPS53 AGRN	9.62e-05	196	262	10	4443_UP
Drug	daunorubicin HCl; Up 200; 1uM; PC3; HT_HG-U133A	ABCA2 SIGLEC8 KDM6B STAC OLFML2A MIA2 MRC2 RTL10 OBSL1 RAB11FIP3	9.62e-05	196	262	10	7511_UP
Drug	6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; MCF7; HT_HG-U133A	ABCA2 DBN1 DDX54 SLC52A2 PIM2 SZT2 RTL10 YY1 CTDP1 PSD4	9.62e-05	196	262	10	7346_DN
Drug	Butylparaben [94-26-8]; Down 200; 20.6uM; HL60; HT_HG-U133A	SRCAP ARHGEF11 DDX54 TSC22D4 PIM2 DLGAP4 EML3 SBNO2 ZFHX2 ELK4	9.62e-05	196	262	10	3069_DN
Drug	estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A	SPHK2 ABCA2 OLFML2A VGF PIM2 DLGAP4 ARHGEF12 HIVEP3 CELSR2 GAB1	9.62e-05	196	262	10	1666_UP
Drug	Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; HL60; HT_HG-U133A	SRCAP ARHGEF11 MRC2 SGSM2 TSC22D4 PIM2 SZT2 RTL10 ZFHX2 AGRN	9.62e-05	196	262	10	2158_DN
Drug	Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A	ABCA2 PCDHA9 BCORL1 SRPRA DDX54 PIM2 PCDHA6 EML3 HIVEP3 SUGP2	9.62e-05	196	262	10	3324_DN
Drug	Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A	ABCA2 SRCAP MIA2 VGF ARHGEF12 YY1 HIVEP3 CTDP1 DZIP3 ELK4	9.62e-05	196	262	10	4276_DN
Drug	Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	PDE4B SRPRA SRCAP USP19 MIA2 NUMA1 OBSL1 YY1 DZIP3 AGRN	9.62e-05	196	262	10	2936_DN
Drug	beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; PC3; HT_HG-U133A	SF3A1 ARHGEF11 TBC1D4 TMEM259 MRC2 RTL10 ARHGEF12 PLEKHO2 DZIP3 SNAPC2	9.62e-05	196	262	10	6638_DN
Drug	Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	ABCA2 ARMCX2 ROBO3 VAV2 NUMA1 TNS2 SBNO2 PLEKHG3 ZBTB3 PSD4	9.62e-05	196	262	10	2225_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A	SRCAP STAC GGA3 FANCA MGAT3 TSC22D4 DLGAP4 PCDHA5 SBNO2 GAB1	1.00e-04	197	262	10	2324_UP
Drug	Clebopride maleate [84370-95-6]; Up 200; 8.2uM; PC3; HT_HG-U133A	SETD1B KDM6B HOXA1 PTPN14 MIA2 SGSM2 SHROOM2 SBNO2 CELSR2 ELK4	1.00e-04	197	262	10	6311_UP
Drug	FK-506; Up 200; 1uM; MCF7; HG-U133A	ABR SF3A1 AXIN1 MRC2 VAV2 NUMA1 SBNO2 MAP7D1 TTLL4 AGRN	1.00e-04	197	262	10	284_UP
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A	DBN1 AXIN1 SLC52A1 DLGAP4 YY1 SBNO2 PLEKHO2 EGFL7 VPS53 PSD4	1.00e-04	197	262	10	3618_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA	ABCA2 DBN1 SRCAP ARHGEF11 PTPN14 TBC1D4 VGF SBNO2 ZFHX2 VPS53	1.00e-04	197	262	10	1013_UP
Drug	Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; MCF7; HT_HG-U133A	PDE4B KDM6B ARHGEF11 FANCA PNPLA6 MTCL1 ZNF574 VGF MAP7D1 AGRN	1.00e-04	197	262	10	3484_UP
Drug	Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; HL60; HT_HG-U133A	TRADD ARHGEF11 USP19 MRC2 TSC22D4 PDLIM2 ADGRL3 NUMA1 SYDE1 ELK4	1.00e-04	197	262	10	2498_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A_EA	SPHK2 ABCA2 BCORL1 ADGRL3 PIM2 DLGAP4 SBNO2 ARR3 SUGP2 PSD4	1.00e-04	197	262	10	984_UP
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; MCF7; HT_HG-U133A	KDM6B USP19 MIA2 NR1H2 ZNF574 SH2B3 EML3 PLEKHG3 LTBP1 EGFL7	1.00e-04	197	262	10	1496_DN
Drug	Androsterone [53-41-8]; Up 200; 13.8uM; HL60; HT_HG-U133A	PDE4B SRCAP SGSM2 ADGRL3 CABP2 NUMA1 TOE1 ARR3 ELK4 PSD4	1.00e-04	197	262	10	1296_UP
Drug	Convolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A	BCORL1 DBN1 KDM6B CASZ1 AXIN1 ZNF574 PIM2 SH2B3 ELK4 IL4R	1.00e-04	197	262	10	7230_DN
Drug	Memantine Hydrochloride [41100-52-1]; Up 200; 18.6uM; HL60; HT_HG-U133A	DBN1 OLFML2A ZNF574 CABP2 DLGAP4 LTBP1 SNAPC2 FYB1 VPS53 RAB11FIP3	1.00e-04	197	262	10	2934_UP
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	KDM6B USP19 FANCA MIA2 DLGAP4 YY1 SBNO2 FYB1 IL4R GAB1	1.05e-04	198	262	10	6023_DN
Drug	Diperodon hydrochloride [537-12-2]; Down 200; 9.2uM; PC3; HT_HG-U133A	PCDHA9 AXIN1 GGA3 HOXA1 OLFML2A DDX54 HIVEP3 GAB1 PSD4 RAB11FIP3	1.05e-04	198	262	10	4498_DN
Drug	Harmane hydrochloride [21655-84-5]; Down 200; 18.2uM; PC3; HT_HG-U133A	ABCA2 CASZ1 MIA2 GLI2 PDLIM2 ARHGEF12 TNS2 SYDE1 AATK ELK4	1.05e-04	198	262	10	4584_DN
Drug	Monocrotaline [315-22-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	ABCA2 BCORL1 SRCAP TBC1D4 ZNF574 VGF DLGAP4 YY1 PLEKHO2 PLEKHG3	1.05e-04	198	262	10	2749_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HG-U133A	SPHK2 ZNF142 FANCA MRC2 DLGAP4 HIVEP3 AATK ELK4 EGFL7 AGRN	1.05e-04	198	262	10	347_DN
Drug	Midecamycin [35457-80-8]; Up 200; 5uM; HL60; HG-U133A	ARHGEF11 USP19 FANCA OLFML2A TBC1D4 SBNO2 MTMR4 ZFHX4 FYB1 TP53BP2	1.05e-04	198	262	10	2026_UP
Drug	haloperidol; Down 200; 10uM; PC3; HT_HG-U133A	HOXA1 OLFML2A SGSM2 ZNF574 NUMA1 EML3 CELSR2 ELK4 SNAPC2 VPS53	1.05e-04	198	262	10	1244_DN
Drug	Propidium iodide [25535-16-4]; Down 200; 6uM; MCF7; HT_HG-U133A	ABCA2 BCORL1 SRCAP ARMCX2 FANCA TSC22D4 ZNF574 NUMA1 IL4R GAB1	1.05e-04	198	262	10	6104_DN
Drug	Nifenazone [2139-47-1]; Down 200; 13uM; MCF7; HT_HG-U133A	ABCA2 KDM6B PRR14 PTPN14 TMEM259 NR1H2 SH2B3 EML3 TTLL4 PSD4	1.05e-04	198	262	10	6016_DN
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A	DBN1 ARMCX2 FANCA GLI2 CABP2 YY1 PRX HIVEP3 GAB1 PSD4	1.05e-04	198	262	10	6800_UP
Drug	Drofenine hydrochloride [548-66-3]; Up 200; 11.4uM; HL60; HT_HG-U133A	SPHK2 ABCA2 MYOM1 SIGLEC8 STAC OLFML2A MGAT3 VAV2 PCDHA6 TYMP	1.05e-04	198	262	10	2714_UP
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A	ABCA2 SRPRA MIA2 ARHGEF12 CHD9 EML3 SYDE1 SNAPC2 ZBTB3 RAB11FIP3	1.05e-04	198	262	10	5304_UP
Drug	Hemicholinium bromide [312-45-8]; Down 200; 7uM; HL60; HG-U133A	TRADD GAK SETD1B DLGAP4 NUMA1 SUGP2 AGRN IL4R TP53BP2 PSD4	1.05e-04	198	262	10	1601_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A	SPHK2 KDM6B PIM2 SZT2 OBSL1 YY1 CTDP1 EGFL7 GAB1 RAB11FIP3	1.05e-04	198	262	10	3258_UP
Drug	Iodipamide [606-17-7]; Up 200; 3.6uM; PC3; HT_HG-U133A	SPHK2 SIGLEC8 ARHGAP22 SLC52A1 ARHGEF12 SYDE1 PLEKHG3 ELK4 SNAPC2 FYB1	1.09e-04	199	262	10	5085_UP
Drug	Corticosterone [50-22-6]; Down 200; 11.6uM; PC3; HT_HG-U133A	MGAT3 VGF NUMA1 CELSR2 SUGP2 TTLL4 CTDP1 DZIP3 VPS53 GAB1	1.09e-04	199	262	10	4064_DN
Drug	Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; HL60; HT_HG-U133A	SRCAP AXIN1 OLFML2A PDLIM2 ADGRL3 PIM2 NUMA1 OBSL1 YY1 SBNO2	1.09e-04	199	262	10	2449_DN
Drug	Ethamivan [304-84-7]; Down 200; 18uM; MCF7; HT_HG-U133A	BCORL1 SRCAP BCOR MTCL1 PDLIM2 ARHGEF12 PCDHA6 YY1 EML3 SUGP2	1.09e-04	199	262	10	7021_DN
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; HL60; HG-U133A	PDE4B DBN1 SRCAP PTPN4 TBC1D4 NR1H2 EML3 AATK TTLL4 FYB1	1.09e-04	199	262	10	2028_UP
Drug	Ald1.1-H_000455; Down 200; 10uM; PC3; HT_HG-U133A	SIGLEC8 STAC FANCA OLFML2A DDX54 TSC22D4 ROBO3 EML3 CELSR2 PSD4	1.09e-04	199	262	10	7547_DN
Drug	Pizotifen malate [5189-11-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A	TRADD OLFML2A TMEM259 EML3 HIVEP3 ARR3 PLEKHO2 DZIP3 ZFHX2 RAB11FIP3	1.09e-04	199	262	10	6513_DN
Drug	Saquinavir mesylate [149845-06-7]; Up 200; 5.2uM; MCF7; HT_HG-U133A	SF3A1 SRCAP PNPLA6 MIA2 CABP2 NUMA1 YY1 TTLL4 CTDP1 IL4R	1.14e-04	200	262	10	6246_UP
Drug	Rifabutin [72559-06-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A	KDM6B AXIN1 TMEM259 VAV2 EML3 SBNO2 STC2 ZBTB3 PSD4	2.93e-04	184	262	9	4349_DN
Drug	retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA	KDM6B ARHGEF11 AXIN1 ARID5B SLC52A2 ZNF574 DLGAP4 MUS81 EML3	3.17e-04	186	262	9	966_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	ZNF142 AXIN1 SGSM2 ADGRL3 PIM2 NUMA1 SBNO2 HIVEP3 SNAPC2	4.01e-04	192	262	9	2450_DN
Drug	Cyanocobalamin [68-19-9]; Down 200; 3uM; MCF7; HT_HG-U133A	TRADD DBN1 SRCAP GGA3 OLFML2A DDX54 SLC52A1 EGFL7 VPS53	4.01e-04	192	262	9	4395_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; HL60; HT_HG-U133A	TRADD SPHK2 MRC2 PDLIM2 ZNF574 NPDC1 PLEKHG3 ZBTB3 PSD4	4.16e-04	193	262	9	3124_DN
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A	ABCA2 SRPRA KDM6B ARHGEF11 TMEM259 NUMA1 SBNO2 VPS53 PSD4	4.16e-04	193	262	9	3624_DN
Drug	Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A	BCORL1 DBN1 SOWAHC MIA2 VAV2 SH2B3 SYDE1 PLEKHG3 VPS53	4.16e-04	193	262	9	3479_DN
Drug	2-deoxy-D-glucose; Down 200; 10000uM; MCF7; HG-U133A	ZNF142 SRCAP STAC FANCA MRC2 SZT2 SBNO2 AATK PLEKHG3	4.32e-04	194	262	9	344_DN
Drug	Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A	ABCA2 USP19 SGSM2 NR1H2 VAV2 SYDE1 SBNO2 PSD4 RAB11FIP3	4.32e-04	194	262	9	6769_UP
Drug	Estropipate [7280-37-7]; Down 200; 9.2uM; MCF7; HT_HG-U133A	PDE4B OLFML2A TMEM259 DLGAP4 YY1 PLEKHG3 EGFL7 GAB1 PSD4	4.32e-04	194	262	9	6068_DN
Drug	0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A	AXL AXIN1 TMEM259 GLI2 TSC22D4 PDLIM2 VAV2 SBNO2 AGRN	4.32e-04	194	262	9	4331_DN
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A	ABCA2 BCORL1 CASZ1 PTPN4 MRC2 DDX54 DLGAP4 EML3 AATK	4.32e-04	194	262	9	1377_DN
Drug	Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A	BCORL1 HOXA1 MGAT3 FOXH1 COL11A1 SZT2 ZBTB7B SYDE1 ZFHX4	4.32e-04	194	262	9	3938_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	SRCAP AXIN1 DDX54 NUMA1 TYMP ZFHX4 LTBP1 MYO15A GAB1	4.32e-04	194	262	9	6171_DN
Drug	Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A	BCORL1 KDM6B BCOR AXIN1 PIM2 DLGAP4 YY1 MAP7D1 ELK4	4.32e-04	194	262	9	7001_DN
Drug	2-propylpentanoic acid; Down 200; 50uM; HL60; HT_HG-U133A	TRADD FANCA PTPN4 DDX54 YY1 EML3 PLEKHG3 IL4R RAB11FIP3	4.48e-04	195	262	9	1163_DN
Disease	1,5 anhydroglucitol measurement	PCDHA9 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	1.19e-10	29	260	8	EFO_0008009
Disease	visceral adipose tissue measurement, body mass index	PCDHA9 RREB1 ADAMTS2 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	5.23e-09	87	260	10	EFO_0004340, EFO_0004765
Disease	neutrophil count, basophil count	PCDHA9 ZBTB16 RREB1 SH2B3 ZNF316 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 SP7	1.11e-07	224	260	13	EFO_0004833, EFO_0005090
Disease	neutrophil count	TRNP1 SPHK2 PCDHA9 ZBTB16 BCORL1 RREB1 KDM6B CASZ1 FANCA PTPN14 TBC1D14 SERTAD1 CELF5 COL11A1 SH2B3 ZNF316 ARHGEF12 MUS81 PCDHA13 PCDHA12 CHD9 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 ZBTB7B SBNO2 HIVEP3 AATK SP7	1.92e-06	1382	260	31	EFO_0004833
Disease	Adenoid Cystic Carcinoma	BCORL1 KDM6B SRCAP BCOR FANCA ARID5B EFHD1	3.03e-05	100	260	7	C0010606
Disease	pulse pressure measurement	PCDHA9 SYNPO2L RREB1 KDM6B SRCAP CASZ1 ARL6IP6 MRC2 ROBO3 SHROOM3 COL11A1 DLGAP4 ARHGEF12 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 ADAMTS8 YY1 FMNL3 HIVEP3 ZFHX4 FAM171A2 PLEKHO2 LTBP1	4.45e-05	1392	260	28	EFO_0005763
Disease	RELA fusion-positive ependymoma	RELA ZFTA	7.73e-05	2	260	2	C4289581
Disease	post-traumatic stress disorder symptom measurement	LRRC37A2 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1	8.84e-05	82	260	6	EFO_0008535
Disease	resting heart rate, chronic obstructive pulmonary disease	SYNPO2L CASZ1 CTAGE1 EEFSEC	1.35e-04	30	260	4	EFO_0000341, EFO_0004351
Disease	Global developmental delay	ZNF142 APC2 PRR12 ALKBH8 TET3 SZT2 VPS53	1.84e-04	133	260	7	C0557874
Disease	urinary albumin to creatinine ratio	ZBTB16 MYOM1 SF3A1 SOWAHC CASZ1 COL4A4 SHROOM3 NUMA1	1.99e-04	179	260	8	EFO_0007778
Disease	Brown-Vialetto-Van Laere syndrome (implicated_via_orthology)	SLC52A2 SLC52A1	2.31e-04	3	260	2	DOID:0050694 (implicated_via_orthology)
Disease	four-jointed box protein 1 measurement	LDLRAD3 CELSR2	2.31e-04	3	260	2	EFO_0801605
Disease	Malignant neoplasm of breast	APC2 BCORL1 LRRC37A2 DBN1 GGA3 PTPN14 ALKBH8 LRRC37A MIA2 TSC22D4 ZNF541 COL11A1 RELA TACC2 MAGEE1 SHROOM2 LLGL2 STC2 ZBTB3 PCDH8 GAB1 TP53BP2	2.34e-04	1074	260	22	C0006142
Disease	vital capacity	PCDHA9 ZBTB16 CDK12 AMZ1 RREB1 CASZ1 MRC2 ARID5B MTCL1 SHROOM3 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 PCDHA1 ADAMTS8 HVCN1 EML3 LLGL2 LTBP1 EGFL7 GAB1	2.68e-04	1236	260	24	EFO_0004312
Disease	Abnormality of refraction	PCDHA9 CDK12 ARL6IP6 FAM110C ADGRL3 CABP2 PCDHA13 PCDHA12 PCDHA8 PCDHA6 PCDHA5 PCDHA3 YBX3 PCDHA1 ZBTB7B HIVEP3	3.45e-04	673	260	16	HP_0000539
Disease	Abnormal behavior	BCORL1 PRR12 MED12L	3.48e-04	16	260	3	C0233514

Protein segments in the cluster

Peptide	Gene	Start	Entry
VSPTPPEGLAPGVEA	ABR	71	Q12979
SPPVRDPEGVTQAPG	CTDP1	356	Q9Y5B0
SAPPSEGTPPIQEEG	SLC4A3	116	P48751
EREGPSLGPPPVASA	RNF40	616	O75150
PPQPAPGKVESGAGD	CDK12	1086	Q9NYV4
GPPRVAPNPTGVDSA	EGFL7	181	Q9UHF1
IGAETQEPEPAPGTP	ANKLE1	141	Q8NAG6
PGPDPPNSISLESGK	ANKRD34C	386	P0C6C1
SEAPLPPGGPAEAIK	AMZ1	391	Q400G9
LQRSLEPPPGSPGEA	CCDC88B	426	A6NC98
AENEATGPGFVPPPL	CTAGE1	651	Q96RT6
KPVEPFGPIGSQDPS	ALKBH8	606	Q96BT7
PAQVKPEPGESTGAP	CASZ1	906	Q86V15
EGASEPPPPLGATSR	ADAMTS8	196	Q9UP79
QPGEEVTPGPEPCSK	ADORA2A-AS1	6	P86434
EPLEGSSVATPGPPV	AGRN	1086	O00468
TTQPAPDGVPGPLAD	BCORL1	536	Q5H9F3
GFIVPPNKDGTPPEG	ADGRL3	1421	Q9HAR2
KPGPVEPASSQPEEA	RTL10	281	Q7L3V2
GAQAPGPSVPTREPE	ALPK3	431	Q96L96
ALPESGQSEPGPPEV	ARHGEF11	1336	O15085
FQAPGSPEEGVRSPP	C1orf216	71	Q8TAB5
VRSPPEGAEIPGAEP	C1orf216	81	Q8TAB5
QGSPGPTLLVEPPDF	COL4A4	251	P53420
AIISQKGTPGEPGPP	COL4A4	966	P53420
ETPPVVRPAGPGEAQ	CELSR2	2211	Q9HCU4
QPATPGGDTAQTPKP	CDHR5	531	Q9HBB8
VGQSAEPPKPSVEPA	BCOR	831	Q6W2J9
VTRGGVAPAPEAPEP	DLGAP4	621	Q9Y2H0
PPPGVTEALGAAEAP	ARMCX2	141	Q7L311
NSQGKPGSPEPETEP	TP53BP2	666	Q13625
APPEAGPGPSAQTIR	ARR3	171	P36575
PQFRSELSSGPGPPV	ATG2A	676	Q2TAZ0
EPTQPDGPTTLGPLD	GRAMD1A	321	Q96CP6
PVRTPSFPGGNEEEP	ADAMTS2	91	O95450
GRPPGSPQIPLADSE	ARHGEF12	146	Q9NZN5
APPGEGISAAPTVEP	ASH2L	41	Q9UBL3
SSRQLGLPGPPDVPD	ITIH4	666	Q14624
TPEPEAGEVSPPVGA	PCDHA9	846	Q9Y5H5
PGAGEKTPDPQAASP	RAB44	341	Q7Z6P3
PDPNQEPGSTPEGRL	RAB44	466	Q7Z6P3
LDLVGPTPATPAAPG	ADARB2	261	Q9NS39
HPLPSEPVGSQEDGP	RAB11FIP3	191	O75154
PVPGTPKEPSLGEQS	MTCL1	311	Q9Y4B5
SPSQETPGDGKPPAL	PTPN4	451	P29074
DIPSSPEKPTPNGGI	PTPN4	496	P29074
SPPPASPDGVTEIRG	NIBAN2	641	Q96TA1
AGLVGTPPESPSEPR	PALM3	146	A6NDB9
TPEPEAGEVSPPVGA	PCDHA6	846	Q9UN73
GTSPDDVQPGPSVGP	NOSIP	136	Q9Y314
LQPAERPLPSPGSGE	OBSL1	111	O75147
AEDRAVPSAPTGPGP	FHIP1B	81	Q8N612
EDQLPTEPPSGPSGL	NPHS1	1046	O60500
LQPPGAAGAAPEPET	OTUD1	36	Q5VV17
VLVLSPEEPGPGPAA	PODN	51	Q7Z5L7
GPTGDPVKPTSLETP	PNPLA6	396	Q8IY17
PPEGSAGVARSQPPV	CASKIN1	436	Q8WXD9
TPEPEAGEVSPPVGA	PCDHA8	846	Q9Y5H6
PPTEGDCGPGKPTLV	PCDHA3	726	Q9Y5H8
TPEPEAGEVSPPVGA	PCDHA3	846	Q9Y5H8
VKSDEPPGPSEQVGP	LRRC37A3	201	O60309
PGQPGPQEGTAEPRD	LDLRAD3	321	Q86YD5
GPAVGPSEAPEQTPE	GPR62	336	Q9BZJ7
STGDGPVPVPPEVEQ	MED12L	211	Q86YW9
PNAPGLPADVPGSDV	MAGEE1	31	Q9HCI5
LPADVPGSDVPQGPS	MAGEE1	36	Q9HCI5
PVPFEGLEESPNGPK	MAGEE1	566	Q9HCI5
GSRLGPPEAESPSQP	FOXH1	6	O75593
TGNSGEEAVPTPPLP	FOXH1	196	O75593
PIDGGTSLTPAPPQR	LLGL2	421	Q6P1M3
VKSDEPPGPSEQVGP	LRRC37A2	201	A6NM11
VKSDEPPGPSEQVGP	LRRC37A	201	A6NMS7
VTPQASPEPGGPDLL	MGAT3	56	Q09327
GVTTLGDPEVAPPPA	DNAAF2	411	Q9NVR5
PEAQPTSVGTGPPAK	MYO15A	2496	Q9UKN7
ELEAPAQGSPPSPGE	CSRNP1	311	Q96S65
AQGSPPSPGEEALVP	CSRNP1	316	Q96S65
ELPPQSGPAPTTDRG	MAPK8IP1	216	Q9UQF2
GFNPTEEDPVKPPGS	GAB1	116	Q13480
EEDPVKPPGSSLQAP	GAB1	121	Q13480
AGQEPSPKPGTDVIP	FLYWCH1	16	Q4VC44
PQVLDPEASGGRPPS	KIF12	526	Q96FN5
LPDPTTNPSAGKDGP	LRRC47	531	Q8N1G4
QPPPTPVSGEEGRAA	HVCN1	56	Q96D96
VQPVPPAALSGPSGE	KDM6B	206	O15054
EDSSEGGLSPLPPQP	BSN	816	Q9UPA5
STATGPQPAGPPRAE	BSN	3826	Q9UPA5
EGPVGPAPSRPALQE	DDX54	616	Q8TDD1
DKPTSPPNEEFGPGV	COL11A1	391	P12107
EEPPGEPQAAQSPAG	IRAG1	51	Q9Y6F6
LPRSPTQDAAGVGPP	IRAG1	336	Q9Y6F6
GPGVAEPEVATAPPE	LTBP1	791	Q14766
ASPGFGKEPAPPVAV	PCDH8	881	O95206
ELPNGSVKEAPAPTP	PDZK1P1	226	A8MUH7
EAAPEGPGSPETPLQ	PERCC1	71	A0A1W2PR82
DVENGPSPGRSPLDP	PDE4B	96	Q07343
PGPQSPGSPLEEERQ	NCF1	341	P14598
PETLFETVGQGPPPS	FBXO36	6	Q8NEA4
LGPKSGPTPPTSENE	FYB1	151	O15117
QGAAEPSRGPPLPSA	COPRS	11	Q9NQ92
SSPPDNKPGGDLPAL	KIF24	1116	Q5T7B8
QSLGTPVTPELPGPD	MRC2	646	Q9UBG0
AQPAVAEGGPAREPP	KIF26A	11	Q9ULI4
DPAPNVPPKESAGNS	GGA3	401	Q9NZ52
ELGVPDSALAGVPPP	GLI2	1301	P10070
APSPSLPGEPGKAAD	LBHD2	76	A0A0U1RRK4
RPLSAENPGGEPEAP	LONRF2	111	Q1L5Z9
QAQAPPRGPGSPAED	DBN1	406	Q16643
GLLPISPATPPGNDE	HOXA1	291	P49639
GQTSVAPPPEEVEPG	MIEN1	6	Q9BRT3
ATPEPEAGEVSPPVG	PCDHA5	831	Q9Y5H7
EQPRAGSSTPGDAPP	HUWE1	2881	Q7Z6Z7
LPAPVGDAVPPSAGL	DZIP3	1011	Q86Y13
PDKPAPGAVNVPAAG	GTSE1	261	Q9NYZ3
GEVGLPPPLPSSQKD	MTMR4	671	Q9NYA4
KAVGVSQEGPPGLPP	NUTM1	146	Q86Y26
TPEPEAGEVSPPVGA	PCDHA1	846	Q9Y5I3
TPEPEAGEVSPPVGA	PCDHA13	846	Q9Y5I0
EGTAPGPARAFPQPD	FAM171A2	566	A8MVW0
APGSPAAPRISPGDQ	NPDC1	226	Q9NQX5
EGQPPGAAKPALAPS	POM121	976	Q96HA1
VQSTPRGGPPAAADP	GAK	946	O14976
LGPEPAARTPEGSPV	APC2	96	O95996
SPSLETREPPGAPAG	APC2	2206	O95996
SDPSVPTPPGAGVKE	CHD9	2311	Q3L8U1
APDPSPGGVPLEASL	IL4R	761	P24394
QAVPGSGDSQPDDPP	BRME1	181	Q0VDD7
EAPPEQLFPSGNKPG	BRME1	551	Q0VDD7
EGPIPGPQSRLSPTA	BCL6B	246	Q8N143
ALGNTVPAVEPGTPP	DNAAF3	461	Q8N9W5
DGPSTPGPFSPDLQK	ELK4	416	P28324
DKPGPGPFSDQSEPA	CHD6	2586	Q8TD26
PASAEPAVTEPGLGP	DMAP1	416	Q9NPF5
PAVTEPGLGPDPKDT	DMAP1	421	Q9NPF5
PLAIAVGDATPGPEP	EBF4	436	Q9BQW3
PQKSAAPGTAPEEAP	FCRLA	276	Q7L513
SAEGVPGEPPSVPLL	FMNL3	6	Q8IVF7
SALPEVDVGPPAPGA	FANCA	796	O15360
PRPPVPGEEGELVST	AXIN1	21	O15169
LLQPRPSPVGSSGPE	CELF5	16	Q8N6W0
PAEELQEKGSPAGPP	CRAMP1	636	Q96RY5
PGPPEDALSQGEPAT	CRAMP1	1081	Q96RY5
GPLGLQPPTAKDGPE	HOXD12	81	P35452
SSAERPAGQPPGAVP	GLI4	121	P10075
QEPGLASSPPGRAPL	ABCA2	1231	Q9BZC7
VTGDPLGPPPADTLQ	AKNA	1256	Q7Z591
EKCGPPPPISNGDTT	CFHR4	456	Q92496
TAPDSAGQPPALGPV	TMEM259	491	Q4ZIN3
LEPESPSGQVGPRPA	MAP7D1	66	Q3KQU3
ESGPQLAPLGAPAPE	EFHD1	21	Q9BUP0
PEPSPGFLPVNSDTG	KNDC1	631	Q76NI1
PPAPQGASEEPSGTQ	EML3	106	Q32P44
QLPGSSSEPLEPEPG	EGLN2	16	Q96KS0
VAGKFPQGPSPESPS	C4orf54	1411	D6RIA3
PQGPSPESPSAAKGI	C4orf54	1416	D6RIA3
AGNPETVPTTPGPAA	FAM110C	146	Q1W6H9
GPRAPGSATTQEPPQ	PIWIL3	26	Q7Z3Z3
ISSGVPPDLPGAPSN	SDK1	1061	Q7Z5N4
PSPGPVLSQAPEDEG	SCAP	936	Q12770
PTGPEAGSPERAPVQ	INAVA	306	Q3KP66
SLIPGPSDPGPAVNR	PRRT3	366	Q5FWE3
PSSSPKEQGDPAPGV	CABP2	31	Q9NPB3
VAPISVPENGKGPFP	CDH3	111	P22223
QVPLPKDSTGAADPP	ECSIT	246	Q9BQ95
GPPRLAIQGPEDSPS	MLF2	226	Q15773
GPALVPTPTQPEELG	PTX4	186	Q96A99
LPTEPPSGPEVSSQG	OLFML2A	376	Q68BL7
LPRTQPDGTSVPGEP	NUMA1	1741	Q14980
ATPEPEAGEVSPPVG	PCDHA12	836	Q9UN75
ENEATGPGFVPPPLA	MIA2	1291	Q96PC5
SGPSEPPAAQGRLAP	FOXL3	151	A0A1W2PRP0
TAVRPEGSEPPGFPT	RTN4R	396	Q9BZR6
VPIAEGPAPPAGASL	RTP5	216	Q14D33
PEPEPQAPEGSQAGA	SYDE1	41	Q6ZW31
EPPGPQPGSAESEGL	SYDE1	126	Q6ZW31
PTIPGPPSQGDSRVS	SYNPO2L	186	Q9H987
QSTRVPGIPDPGPEI	SZT2	1401	Q5T011
QDPETADGPPSGQKP	SHD	151	Q96IW2
PPAPSGSQQGPEEEA	VGF	96	O15240
GDGEVASAPLQPPVP	TRADD	171	Q15628
PQQRPPEPETGESAG	TSC22D4	191	Q9Y3Q8
ELGEPFPGAKESPPT	AATK	1251	Q6ZMQ8
GPSQAVKGDPPPISD	PLEKHG3	791	A1L390
PGPLPQSKPDGGETL	PLEKHG3	1116	A1L390
LPGTAPPATPSGFEE	PIANP	81	Q8IYJ0
EDVPLNPSKGGPAPL	PIM2	291	Q9P1W9
PGAPSSSPTVKEEGP	NR1H2	21	P55055
AGGRTVPPNVAPSPD	PRR14	541	Q9BWN1
PPQPELGGLPRTSSE	PRAM1	321	Q96QH2
GVRTGPESPATLEPP	PSD4	276	Q8NDX1
PPEEGSGSHEVPQLP	PTPN14	676	Q15678
QEPPSQAAGTTPGPD	SLC52A2	251	Q9HAB3
TAEPGLPGDTVTPQP	PPP1R16A	481	Q96I34
PKPEQEAGPGTPGTA	SGSM2	676	O43147
KAGISQPDPSQPGPS	SATL1	101	Q86VE3
GSPPEAASEPPTGLR	SIX5	71	Q8N196
PPPAVAPSSGEEGEL	SIGLEC8	431	Q9NYZ4
ASQPSPEPPLGLLDG	SHROOM1	561	Q2M3G4
TPADLGPRAQSPGSP	SHROOM2	1026	Q13796
DPDTPLGAPSTPGRI	SHROOM3	1471	Q8TF72
PGVVPLGTPDAQADP	SBNO2	1286	Q9Y2G9
VSGPLAAPPPEQEGV	SPATA31E1	916	Q6ZUB1
GTPTLESSPAGPEKP	SETD1B	481	Q9UPS6
EGNPFPRESQGPAPS	PPP1R26	806	Q5T8A7
GPSEPSGDPPRIQVT	SOWAHC	86	Q53LP3
EKLFGASSPPPGAVP	TMEM151A	316	Q8N4L1
AGPETPGLGLDPNKP	PRR12	1001	Q9ULL5
AGPKDTSTPDGPPLA	PRR12	1411	Q9ULL5
IAQDSSLDGPPGPPD	SRCAP	51	Q6ZRS2
RLQPPSPLGPEGSVE	SRCAP	3156	Q6ZRS2
APQPLADEGPPGRSI	SERTAD1	131	Q9UHV2
DKPAPGTEPLGPVSS	PROB1	326	E7EW31
GGSQQSPEVAAPEPP	PROB1	576	E7EW31
GESKTQEPPALGPPA	PROB1	661	E7EW31
EQGNFPPPTTPEELG	SF3A1	291	Q15459
AGDSAVLVLPPSPGP	PDLIM2	186	Q96JY6
TQVTELPPGPEDPGK	ARHGAP22	86	Q7Z5H3
SVLPPDGNGSPVLPD	ARL6IP6	71	Q8N6S5
EEAGEKGPTPPLPSA	ARID5B	531	Q14865
GSSQGPKEPQPSPTD	ATF6B	456	Q99941
GDLGSQPPAAKDPSP	CLUH	1291	O75153
ALVPAPSGPDSGQPL	PRXL2C	16	Q7RTV5
SGIPTLEIGNPEPVP	TBC1D14	66	Q9P2M4
RPGTGSQQPEPPAEG	TNIP2	376	Q8NFZ5
GEASIPGQEPPTPSS	PLEKHG5	211	O94827
IIPVAAKPGGPEAPE	EEFSEC	181	P57772
AKPGGPEAPETEAPQ	EEFSEC	186	P57772
PNGECPVKSEPTEPG	ZFHX4	456	Q86UP3
AGEKAVPPGNDPVSP	USP19	231	O94966
ASGVPNGEDSPPQVP	ZBTB7B	171	O15156
APQDPAPKSPVGSGA	YBX3	26	P16989
EAKAGEAPTENPAPP	YBX3	351	P16989
GTLQPPAGPEEPTLA	ZBTB16	216	Q05516
GPEPTPSRDQAAEGP	ZFHX2	1076	Q9C0A1
AKEGNEAGPSSPPDP	ZFHX2	1416	Q9C0A1
VSEGAPVIPPSSGLP	SPHK2	486	Q9NRA0
DGPLAPGQQTDTPPA	RAPGEF1	441	Q13905
LPITQPTPRGGPEET	SARG	86	Q9BW04
PTNGTSGPPLDFPER	SLC52A1	176	Q9NWF4
TTPTAKDGAPGEPPL	SAMD4B	406	Q5PRF9
VETGPSVSEPPGLPR	SPATS1	76	Q496A3
PGSLGLPFPPDIQTE	TRO	21	Q12816
PSEPGQGDLNPESPA	RREB1	1641	Q92766
SPATPEKAPGGSPEQ	SP7	411	Q8TDD2
DSLEPPGEPGPSTNI	TFG	121	Q92734
PGEPGPSTNIPENDT	TFG	126	Q92734
AAEGAKSAEPPPEQP	SOBP	731	A7XYQ1
GQAGDGPKPAELPPT	TMEM247	81	A6NEH6
PPGTGDFPSQVPKQV	PLEKHG4B	176	Q96PX9
LSPPPTEPTDGEQAG	RASGEF1C	16	Q8N431
PARGTDATNPPEGPQ	STC2	21	O76061
PFTGIPEPSEPLAGA	SPRED3	196	Q2MJR0
PTLGLGAPAPPAVEA	PRX	271	Q9BXM0
RSIPEEAPSGPPQGV	ROBO3	761	Q96MS0
PPGGIPGIDLSDPKQ	YY1	261	P25490
AAGPGEVLAKEPPAP	ZNF574	691	Q6ZN55
PKEAVGAEQPPSPAS	STAC	16	Q99469
PVGPSPQDPSLEASG	SUGP2	741	Q8IX01
PSPKPAGVDISEAPQ	SUGP2	756	Q8IX01
PQPFPGPSSVLREGS	HIVEP3	56	Q5T1R4
AAGGADPPTQPDPKD	AXL	836	P30530
PGPPAQTEAPGTIEF	TROAP	106	Q12815
SPEGLPGRSSPPEQI	SH2B3	511	Q9UQQ2
PVPAEKSGLPVGPEN	SRPRA	186	P08240
PGEVPAPSPQERGEH	TACC2	486	O95359
APKTPQNVPASPGGD	RFX7	311	Q2KHR2
ALQPGSTGPLPPADD	TET3	691	O43151
PPKPNTDEGGAVLPS	VPS53	456	Q5VIR6
PEGKPGAGPSPATVV	ZBTB47	251	Q9UFB7
IPSVGPEAEGPRQSP	SNX22	6	Q96L94
LEPEPGVSAQPGPGK	TBC1D4	16	O60343
GENPSPQGELPSPES	ZNF496	26	Q96IT1
VAAPTPSGKVDPAPE	ZNF316	561	A6NFI3
APPDLPTPGSAAGVQ	ZSCAN18	16	Q8TBC5
PTLELQDGPGAPTPV	USP30	376	Q70CQ3
EGPVDKSSPGSPQSP	ZNF687	291	Q8N1G0
EPAKPSQAEGTPGTP	PLEKHO2	351	Q8TD55
GSPVPPAGNSLPTEA	ZNF142	961	P52746
PAPPGKPVLTFQTGD	VAV2	601	P52735
PADAGPEPVGTQEPG	WNK2	111	Q9Y3S1
QSGPSGTVPATPPEK	TTLL4	21	Q14679
VAPPAPKPTQAGEGT	RELA	421	Q04206
PGAQEGTAEQRSPPP	TRNP1	11	Q6NT89
EGSQGLPDPSPEPKQ	TYMP	21	P19971
GIAPSAPGTIPELPT	WASH6P	251	Q9NQA3
DASDPALQPPGGVPS	WNK4	596	Q96J92
APGGQEDPAPEIPSS	SNAPC2	156	Q13487
EVPGSQASPNPVPGD	TOE1	421	Q96GM8
KAPELPSGSGPEPLA	TNS2	956	Q63HR2
FPPPASPERQDGEGT	TIPIN	26	Q9BVW5
ESPQGPIPPGTAAAS	ZFTA	496	C9JLR9
EEPPGASLPGKQAPA	ZNF541	706	Q9H0D2
SKPDPEVGPLLGVQP	ZBTB3	531	Q9H5J0
AQKEPEAAVPAPGPG	GOLGA8CP	401	A6NN73
PGPTTDPLDPKGQGA	LIME1	211	Q9H400
PKEPPGEETAVPGAA	MUS81	231	Q96NY9
EPSEGIVPGPPTDLS	MYOM1	631	P52179